2023
Annual Report
2023 Fiscal Review*
FISCAL YEARS ENDED
SEPTEMBER 30, 2023
OCTOBER 1, 2022
% CHANGE
Net sales
Free cash flow
Adjusted EPS
$12,664
926
7.42
$14,495
876
7.40
-13%
6%
0%
Net Sales
CAGR 9%
$14,495
$13,850
$11,709
$12,664
$15,000
$13,000
$11,000
$9,000
$7,000
$8,878
Adjusted EPS
CAGR 14%
$7.21
$7.40
$7.42
$6.40
$4.33
$8.00
$6.00
$4.00
$2.00
2019
2020
2021
2022
2023
2019
2020
2021
2022
2023
*In millions of dollars, except stock performance data. Free cash flow and adjusted earnings per share are non-GAAP financial measures.
See reconciliation located within this document.
Long-term Targets
Operating EBITDA Growth
Adj. EPS Growth
Total Shareholder Return
Leverage Ratio
4–6%
7–12%
10–15%
2.5x–3.5x
Growing Annual Dividend
Stock Performance**
10 year total return
(since IPO)
BERY = 310%
S&P 500 = 255%
DJUSCP = 159%
$400
$350
$300
$250
$200
$150
$400
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Berry Global Group, Inc.
Dow Jones Containers & Packaging Index
S&P 500 Index
**Total cumulative return based on $100 invested at beginning of the period vs. the S&P 500 and DJ US Containers & Packaging.
Assumes reinvestment of dividends.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended September 30, 2023
OR
For the transition period from
to
Commission File Number 001-35672
A Delaware corporation
BERRY GLOBAL GROUP, INC.
101 Oakley Street, Evansville, Indiana, 47710
(812) 424-2904
IRS employer identification number
20-5234618
Title of Each Class
Securities registered pursuant to Section 12(b) of the Act:
Trading Symbol(s)
Name of Each Exchange on Which Registered
Common Stock, $0.01 par value per share
BERY
New York Stock Exchange LLC
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was
required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act
Large accelerated filer ☒
Small reporting company ☐
Non-accelerated filer ☐
Accelerated filer ☐
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of
internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting
firm that prepared or issued its audit report. ☒
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based
compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934).
Yes ☐ No ☒
The aggregate market value of the common stock of the registrant held by non-affiliates was approximately $6.9 billion as of March 29,
2023, the last business day of the registrant’s most recently completed second fiscal quarter. The aggregate market value was computed using
the closing sale price as reported on the New York Stock Exchange. As of November 17, 2023, there were 115.5 million shares of common stock
outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of Berry Global Group, Inc.’s Proxy Statement for its 2024 Annual Meeting of Stockholders are incorporated by reference into
Part III of this report.
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
Information included in or incorporated by reference in this Form 10-K and other filings with the U.S.
Securities and Exchange Commission (the “SEC”) and the Company’s press releases or other public
statements, contains or may contain forward-looking statements. This report includes “forward-looking”
statements with respect to our financial condition, results of operations and business and our expectations
or beliefs concerning future events. These statements contain words such as “believes,” “expects,” “may,”
“will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “project,”
“outlook,” “anticipates,” or “looking forward” or similar expressions that relate to our strategy, plans,
intentions, or expectations. All statements we make relating to our estimated and projected earnings, margins,
costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future
industry trends are forward-looking statements. In addition, we, through our senior management, from time
to time make forward-looking public statements concerning our expected future operations and
performance and other developments. These forward-looking statements are subject to risks and uncertainties
that may change at any time, and, therefore, our actual results may differ materially from those that we
expected. All forward-looking statements are made only as of the date hereof, and we undertake no obligation
to publicly update or revise any forward-looking statement as a result of new information, future events or
otherwise, except as otherwise required by law.
Additionally, we caution readers that the list of important factors discussed in the section titled “Risk
Factors” may not contain all of the material factors that are important to you. In addition, in light of these
risks and uncertainties, the matters referred to in the forward-looking statements contained in this report
may not in fact occur. Accordingly, readers should not place undue reliance on those statements.
1
TABLE OF CONTENTS
FORM 10-K FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2023
PART I
Item 1.
BUSINESS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 1A. RISK FACTORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 1B. UNRESOLVED STAFF COMMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PROPERTIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 2.
Item 3.
LEGAL PROCEEDINGS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 4. MINE SAFETY DISCLOSURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PART II
Item 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER
MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES . . . . . . . . . . . .
RESERVED . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 6.
Item 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK . . .
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA . . . . . . . . . . . . . . . . .
Item 8.
Reports of Independent Registered Public Accounting Firm (PCAOB ID 42) . . . . . . . . .
Consolidated Statements of Income and Comprehensive Income for fiscal 2023, 2022 and
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Balance Sheets as of fiscal 2023 and 2022 . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Statements of Cash Flows for fiscal 2023, 2022 and 2021 . . . . . . . . . . . . . .
Consolidated Statements of Changes in Stockholders’ Equity for fiscal 2023, 2022 and
2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Notes to Consolidated Financial Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 9A. CONTROLS AND PROCEDURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 9B. OTHER INFORMATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT
Item 9.
Page
3
6
9
9
9
9
10
10
10
15
17
17
20
22
23
24
25
44
44
44
INSPECTIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
44
PART III
Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE . . . . . .
Item 11. EXECUTIVE COMPENSATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
45
45
MANAGEMENT AND RELATED STOCKHOLDER MATTERS . . . . . . . . . . . . . . .
45
Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR
INDEPENDENCE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES . . . . . . . . . . . . . . . . . . . . . . . .
PART IV
Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES . . . . . . . . . . . . . . . . . . .
Item 16. FORM 10-K SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
45
45
46
46
2
Item 1. BUSINESS
(In millions of dollars, except as otherwise noted)
General
Berry Global Group, Inc. (“Berry,” “we,” or the “Company”) is a leading global supplier of a broad
range of innovative rigid, flexible and non-woven products. We sell our products predominantly into stable,
consumer-oriented end markets, such as healthcare, personal care, and food and beverage. Our customers
consist of a diverse mix of global, national, regional and local specialty businesses. For the fiscal year ended
September 30, 2023 (“fiscal 2023”), no single customer represented more than 5% of net sales and our top
ten customers represented 15% of net sales. We believe our manufacturing processes, manufacturing footprint
and our ability to leverage our scale to reduce costs, positions us as a low-cost manufacturer relative to our
competitors.
Additional financial information about our segments is provided in “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” and the “Notes to Consolidated Financial
Statements” sections of this report.
Segment Overview
The Company’s operations are organized into four reporting segments: Consumer Packaging
International, Consumer Packaging North America, Engineered Materials, and Health, Hygiene &
Specialties. The structure is designed to align us with our customers, provide optimal service, drive future
growth, and to facilitate synergy realization.
Consumer Packaging International
The Consumer Packaging International segment is a manufacturer of rigid products that primarily
services non-North American markets. Product groups within the segment include Closures and Dispensing
Systems, Pharmaceutical Devices and Packaging, Bottles and Canisters, Containers, and Technical
Components. In fiscal 2023, Consumer Packaging International accounted for 32% of our consolidated net
sales.
Consumer Packaging North America
The Consumer Packaging North America segment is a manufacturer of rigid products that primarily
services North American markets. Product groups within the segment include Containers and Pails,
Foodservice, Closures, Bottles and Prescription Vials, and Tubes. In fiscal 2023, Consumer Packaging North
America accounted for 24% of our consolidated net sales.
Engineered Materials
The Engineered Materials segment is a manufacturer of flexible products that services primarily North
American and European markets. Product groups within the segment include Stretch and Shrink Films,
Converter Films, Institutional Can Liners, Food and Consumer Films, Retail Bags, and Agriculture Films.
In fiscal 2023, Engineered Materials accounted for 23% of our consolidated net sales.
Health, Hygiene & Specialties
The Health, Hygiene & Specialties segment is a manufacturer of non-woven and related products that
services global markets. Product groups within the segment include Healthcare, Hygiene, Specialties, and
Tapes. In fiscal 2023, Health, Hygiene & Specialties accounted for 21% of our consolidated net sales.
During fiscal 2023, the Company announced that it has initiated a formal process to evaluate strategic
alternatives for its Health, Hygiene and Specialties segment and has determined the segment does not meet
the criteria of Held for Sale as of year end.
3
Marketing, Sales, and Competition
We reach our large and diversified customer base through a direct sales force of dedicated professionals
and the strategic use of distributors. Our scale enables us to dedicate certain sales and marketing efforts to
particular products or customers, when applicable, which enables us to develop expertise that we believe is
valued by our customers.
The major markets in which the Company sells its products are highly competitive. Areas of competition
include service, innovation, quality, and price. This competition is significant as to both the size and the
number of competing firms. Competitors include but are not limited to Amcor, Silgan, Aptar, Pactiv
Evergreen, 3M, and Fitesa.
Raw Materials
Our primary raw material is polymer resin. In addition, we use other materials such as butyl rubber,
adhesives, paper and packaging materials, linerboard, rayon, polyester fiber, and foil, in various manufacturing
processes. While temporary industry-wide shortages of raw materials have occurred, we have historically
been able to manage the supply chain disruption by working closely with our suppliers and customers.
Changes in the price of raw materials are generally passed on to customers through contractual price
mechanisms over time, during contract renewals and other means.
Intellectual Property
While important to our business in the aggregate, the loss of any single patent or license alone would
not have a material adverse effect on our results of operations as a whole or those of our reportable segments.
Environmental and Sustainability
We believe there will always be a leading role for Berry’s product offerings due to our ability to promote
customer brands by providing superior clarity, protection, design versatility, consumer safety, convenience,
cost efficiency, barrier properties, and environmental performance. We collaborate with customers, suppliers,
and innovators to create industry-leading solutions which offer lighter weight products, enable longer shelf-
life, and protect products throughout supply chains.
Sustainability is comprehensively embedded across our business, from how we run our manufacturing
operations more efficiently to the investments we are making in sustainable packaging. We believe responsible
packaging is the answer to achieving less waste and that responsible packaging requires four things —
innovative design, continued development of renewable and advanced raw materials, waste management
infrastructure, and consumer participation. Berry is committed to responsible packaging and has (1) targeted
100% reusable, recyclable, or compostable packaging by 2025, (2) significantly increased our use of circular
materials in order to meet our targeted 10% recycled content by 2025, and (3) worked to drive greater
recycling rates around the world. With our global scale, deep industry experience, and strong capabilities, we
are uniquely positioned to assist our customer in the design and development of more sustainable
packaging.
We also work globally on continuous improvement of employee safety, energy usage, water efficiency,
waste reduction, recycling and reducing our Green house Gas (GHG) emissions. Our teams focus on
improving the circularity and reducing the carbon footprint of our products. We anticipate higher demand
for products with lower emissions intensity where polymer resin based products are inherently well positioned
since they typically have lower GHG emissions per functional unit compared to heavier alternatives such
as paper, metal and glass. Additionally, there is also significant work being done on the use of recycled and bio-
based content, which typically has lower associated GHG emissions compared to other virgin materials.
Human Capital and Employees
Overview
Berry’s mission of ‘Always Advancing to Protect What’s Important’ has never been more critical as we
are proud to work alongside our customers to supply products that are essential to everyday life. We continue
to prioritize the health and well-being of the communities we serve as well as our employees and their
families.
4
Health and Safety
Employee safety is our number one core value. We believe when it comes to employee safety, our best
should always be our standard. It is through the adherence to our global Environment, Health, and Safety
principles we have been able to identify and mitigate operational risks and drive continuous improvement,
resulting in an OSHA incident rate below 1.0 which is significantly lower than the industry average.
Talent and Development
We seek to attract, develop and retain talent throughout the company. Our succession management
strategy focuses on a structured succession framework and multiple years of performance. Our holistic
approach to developing key managers and identifying future leaders includes challenging assignments, formal
development plans and professional coaching. Resources to support employee development include
operational programs, university partnerships, internal e-learning requirements, tuition reimbursement
programs, and apprenticeships.
Employee Engagement
We seek to ensure that everyone is motivated to perform every day. To further that objective, our
engagement approach focuses on clear communication and recognition. We communicate through regular
employee meetings, at both the corporate and operating division levels, with business and market updates and
information on production, safety, quality and other operating metrics. We have many recognition-
oriented awards throughout our company and conduct company-wide engagement surveys which have
generally indicated high levels of engagement and trust in Berry’s leadership.
Inclusion and Diversity
We strive to build a safe and inclusive culture where employees feel valued and treated with respect. We
believe inclusion helps drive engagement, innovation and organizational growth. We provide annual training
to our diversified global workforce on the importance of having a culture of inclusion.
Ethics
Our employees are expected to act with integrity and we maintain a Global Code of Business Ethics
which is attested by every Berry employee and provides the Company’s framework for ethical business. We
provide targeted annual training across the globe to reinforce our commitment to ethics and drive adherence
to the laws in each jurisdiction in which we operate.
Available Information
We make available, free of charge, our annual reports on Form 10-K, quarterly reports on Form 10-Q,
current reports on Form 8-K and amendments, if any, to those reports through our internet website as soon
as reasonably practicable after they have been electronically filed with the SEC. Our internet address is
www.berryglobal.com. The information contained on our website is not being incorporated herein.
5
Item 1A. RISK FACTORS
Operational Risks
Global economic conditions may negatively impact our business operations and financial results.
Challenging global conditions, including inflation or military conflicts, may negatively impact our
business operations and financial results. When challenging economic conditions exist, our customers may
delay, decrease or cancel purchases from us, and may also delay payment or fail to pay us altogether. Suppliers
may have difficulty filling our orders and distributors may have difficulty getting our products to customers,
which may affect our ability to meet customer demands, and result in a loss of business. Weakened global
economic conditions may also result in unfavorable changes in our product prices, product mix and profit
margins. Although we take measures to mitigate the impact of inflation, including through pricing actions
and productivity programs, if these actions are not effective our cash flow, financial condition, and results
of operations could be adversely impacted. In addition, there could be a time lag between recognizing the
benefit of our mitigating actions versus when the challenge occurs and there is no assurance that our
mitigating measures will be able to fully mitigate the negative impacts.
Political volatility may also contribute to the general economic conditions and regulatory uncertainty
in regions in which we operate. Future unrest and changing policies could result in an adverse impact to our
financial condition. Political developments can also disrupt the markets we serve and the tax jurisdictions
in which we operate and may affect our business, financial condition and results of operations.
Raw material inflation or shortage of available materials could harm our financial condition and results of
operations.
Raw materials are subject to price fluctuations and availability, due to external factors, which are
beyond our control. Temporary industry-wide shortages of raw materials have occurred in the past, which
can lead to increased raw material price volatility. Additionally, our suppliers could experience cost increases
to produce raw material due to increases in carbon pricing. Historically we have been able to manage the
impact of higher costs by increasing our selling prices. We have generally been well positioned to capture
additional market share as our primary raw material, polymer resin, is typically a lower cost and more versatile
substrate compared to alternatives. However, raw material shortages or our inability to timely pass-through
increased costs to our customers may adversely affect our business, financial condition and results of
operations.
Weather related events could negatively impact our results of operations.
Weather related events could adversely impact on our business and those of our customers, suppliers,
and partners. Such events may have a physical impact on our facilities, inventory, suppliers, and equipment
and any unplanned downtime at any of our facilities could result in unabsorbed costs that could negatively
impact our results of operations for the period in which it experienced the downtime. Longer-term changes
in climate patterns could alter future customer demand, impact supply chains and increase operating costs.
However, any such changes are uncertain and we cannot predict the net impact from such events.
We may not be able to compete successfully and our customers may not continue to purchase our products.
We compete with multiple companies in each of our product lines on the basis of a number of
considerations, including price, service, quality, product characteristics and the ability to supply products to
customers in a timely manner. Our products also compete with various other substrates. Some of these
competitive products are not subject to the impact of changes in resin prices, which may have a significant
and negative impact on our competitive position versus substitute products. Additionally, consumer views on
environmental considerations could potentially impact demand for our products that utilize fossil fuel
based materials in their manufacturing. Our competitors may have financial and other resources that are
substantially greater than ours and may be better able than us to withstand higher costs. Competition and
product preference changes could result in our products losing market share or our having to reduce our
prices, either of which could have a material adverse effect on our business, financial condition and results of
6
operations. In addition, since we do not have long-term arrangements with many of our customers, these
competitive factors could cause our customers to shift suppliers and/or packaging material quickly.
We may pursue and execute acquisitions or divestitures, which could adversely affect our business.
Transactions involve special risks, including the potential assumption of unanticipated liabilities and
contingencies as well as difficulties in integrating acquired businesses or carving-out divested businesses,
which may result in substantial costs, delays or other problems that could adversely affect our business,
financial condition and results of operations. Furthermore, we may not realize all of the synergies we expect
to achieve from our current strategic initiatives due to a variety of risks. If we are unable to achieve the
benefits that we expect to achieve from our strategic initiatives, it could adversely affect our business, financial
condition and results of operations.
In the event of a catastrophic loss of one of our key manufacturing facilities, our business would be adversely
affected.
While we manufacture our products in a large number of diversified facilities and maintain insurance
covering our facilities, including business interruption insurance, a catastrophic loss of the use of all or a
portion of one of our key manufacturing facilities due to accident, labor issues, weather conditions, natural
disaster, pandemic or otherwise, whether short or long-term, could result in future losses.
Employee retention, labor cost inflation or the failure to renew collective bargaining agreements could disrupt
our business.
Our relations with employees under collective bargaining agreements remain satisfactory and there
have been no significant work stoppages or other labor disputes during the past four years. However, we
may not be able to maintain constructive relationships with labor unions or trade councils and may not be
able to successfully negotiate new collective bargaining agreements on satisfactory terms in the future.
Labor is subject to cost inflation, availability and workforce participation rates, all of which could be
impacted by factors beyond our control. As a result, there can be no assurance we will be able to recruit,
train, assimilate, motivate and retain employees in the future. The loss of a substantial number of these
employees or a prolonged labor dispute could disrupt our business and result in future losses.
We depend on information technology systems and infrastructure to operate our business, and increased
cybersecurity threats, system inadequacies, and failures could disrupt our operations, compromise customer,
employee, vendor and other data which could negatively affect our business.
We rely on the efficient and uninterrupted operation of information technology systems and networks.
These systems and networks are vulnerable to increased threats and more sophisticated computer crime,
energy interruptions, telecommunications failures, breakdowns, natural disasters, terrorism, war, computer
malware or other malicious intrusions.
We also maintain and have access to data and information that is subject to privacy and security laws,
regulations, and customer controls. Despite our efforts to protect such information, breaches, misplaced or
lost data and programming damages could result in a negative impact on the business. While we have not had
material system interruptions historically associated with these risks, there can be no assurance from future
interruptions that could result in future losses.
Financial and Legal Risks
Our substantial indebtedness could affect our ability to meet our obligations and may otherwise restrict our
activities.
We have a significant amount of indebtedness, which requires significant interest payments. The
amount of interest charges could increase materially due to rising interest rates as indebtedness is refinanced,
interest rate swaps expire, or accounts receivable supply chain finance factoring grows. Our inability to
generate sufficient cash flow to satisfy our debt obligations, or to refinance our obligations on commercially
7
reasonable terms, would have a material adverse effect on our business, financial condition and results of
operations. Additionally, servicing the interest obligations of our existing indebtedness could limit our ability
to respond to business opportunities, including growing our business through acquisitions or increased
levels of capital expenditures.
Goodwill and other intangibles represent a significant amount of our net worth, and a future write-off could
result in lower reported net income and a reduction of our net worth.
We have a substantial amount of goodwill. Future changes in market multiples, cost of capital,
expected cash flows, or other external factors, may adversely affect our business and cause our goodwill to
be impaired, resulting in a non-cash charge against results of operations to write off goodwill or indefinite
lived intangible assets for the amount of impairment. If a future write-off is required, the charge could
result in significant losses.
Our international operations pose risks to our business that may not be present with our domestic operations.
We are subject to foreign exchange rate risk, both transactional and translational, which may negatively
affect our financial performance. Exchange rates between transactional currencies may change rapidly due
to a variety of factors. In particular, our translational exposure may be impacted by movements in the exchange
rate of the euro or the British pound sterling against the U.S. dollar.
Foreign operations are also subject to certain risks that are unique to doing business in foreign
countries including supply chain challenges, disruption of energy, changes in applicable laws, including
assessments of income and non-income related taxes, inability to readily repatriate cash to the U.S. effectively,
and regulatory policies and various trade restrictions including potential changes to taxes or duties. We are
also subject to the Foreign Corrupt Practices Act and other anti-bribery and anti-corruption laws that
generally bar bribes or unreasonable gifts to foreign governments or officials. We have implemented safeguards,
training and policies to discourage these practices by our employees and agents. However, if employees
violate our policies, we may be subject to regulatory sanctions. Any of these risks could disrupt our business
and result in significant losses.
Current and future environmental and other governmental requirements could adversely affect our financial
condition and our ability to conduct our business.
While we have not been required historically to make significant capital expenditures in order to
comply with applicable environmental laws and regulations, we cannot predict our future capital expenditure
requirements because of continually changing compliance standards and environmental technology.
Furthermore, violations or contaminated sites that we do not know about (including contamination caused
by prior owners and operators of such sites or newly discovered information) could result in additional
compliance or remediation costs or other liabilities. In addition, federal, state, local, and foreign governments
could enact laws or regulations concerning environmental matters, such as greenhouse gas (carbon)
emissions, that increase the cost of producing, or otherwise adversely affect the demand for our products.
Additionally, several governmental bodies in jurisdictions where we operate have introduced, or are
contemplating introducing, regulatory change to address the potential impacts of changes in climate and
global warming, which may have adverse impacts on our operations or financial results. We believe that any
such laws promulgated to date have not had a material adverse effect on us, as we have historically been
able to manage the impact of higher costs by increasing our selling prices. However, there can be no assurance
that future legislation or regulation would not have a material adverse effect on us.
Changes in tax laws or changes in our geographic mix of earnings could have a material impact on our
financial condition and results of operation.
We are subject to income and other taxes in the many jurisdictions in which we operate. Tax laws and
regulations are complex and the determination of our global provision for income taxes and current and
deferred tax assets and liabilities requires judgment and estimation. We are subject to routine examinations
of our income tax returns, and tax authorities may disagree with our tax positions and assess additional tax.
Our future income taxes could also be negatively impacted by our mix of earnings in the jurisdictions in
which we operate being different than anticipated given differences in statutory tax rates in the countries in
8
which we operate. In addition, tax policy efforts to raise global corporate tax rates could adversely impact
our tax rate and subsequent tax expense.
We may not be successful in protecting our intellectual property rights, including our unpatented proprietary
know-how and trade secrets, or in avoiding claims that we infringed on the intellectual property rights of others.
In addition to relying on patent and trademark rights, we rely on unpatented proprietary know-how
and trade secrets, and employ various methods, including confidentiality agreements with employees and
consultants, customers and suppliers to protect our know-how and trade secrets. However, these methods and
our patents and trademarks may not afford complete protection and there can be no assurance that others
will not independently develop the know-how and trade secrets or develop better production methods than us.
Further, we may not be able to deter current and former employees, contractors and other parties from
breaching agreements and misappropriating proprietary information and it is possible that third parties may
copy or otherwise obtain and use our information and proprietary technology without authorization or
otherwise infringe on our intellectual property rights. Furthermore, no assurance can be given that we will
not be subject to claims asserting the infringement of the intellectual property rights of third parties seeking
damages, the payment of royalties or licensing fees and/or injunctions against the sale of our products.
Any such litigation could be protracted and costly and could result in significant losses.
We may be subject to litigation and regulatory investigations and proceedings, including product liability
claims, that could adversely affect our business operations and financial performance.
In the ordinary course of our business, we are involved in legal proceedings, including product liability
claims, which may lead to financial or reputational damages. See Note 5. Commitments, Leases and
Contingencies. We may also be subject to inquiries, inspections, investigations and proceedings by relevant
regulatory and other governmental agencies. Given our global footprint, we are exposed to more uncertainty
regarding the regulatory environment. The timing of the final resolutions to lawsuits, regulatory inquiries,
and governmental and other legal proceedings is typically uncertain, and any such proceedings or claims,
regardless of merit, could be time consuming and expensive to defend and could divert management’s attention
and resources. The possible outcomes of these proceedings could include adverse judgments, settlements,
injunctions, fines, penalties or other results adverse to us that could harm our business, financial condition,
results of operations and reputation and result in significant losses. Even if we are successful in defending
ourselves against these actions, the costs of such defense may be significant to us.
Item 1B. UNRESOLVED STAFF COMMENTS
None.
Item 2. PROPERTIES
Our primary manufacturing facilities by geographic area were as follows:
Geographic Region
Total Facilities
Leased Facilities
US and Canada . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Europe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rest of world . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
102
110
36
18
24
15
Item 3. LEGAL PROCEEDINGS
For information see Note 5. Commitments, Leases and Contingencies
Item 4. MINE SAFETY DISCLOSURES
Not applicable.
9
PART II
Item 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER
MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES
Our common stock “BERY” is listed on the New York Stock Exchange. As of the date of this filing
there were fewer than 550 active record holders of the common stock, but we estimate the number of
beneficial stockholders to be much higher as a number of our shares are held by brokers or dealers for their
customers in street name. During fiscal 2023 the Company declared and paid cash dividends of $0.25 per
share for each quarter. During fiscal 2022 we did not declare or pay any cash dividends on our common stock.
Issuer Purchases of Equity Securities
The following table summarizes the Company’s repurchases of its common stock during the Quarterly
Period ended September 30, 2023.
Total Number of
Shares Purchased
Average Price
Paid Per Share
Total Number of Shares
Purchased as Part of Publicly
Announced Programs
Dollar Value of Shares that
May Yet be Purchased Under
the Program (in millions)(a)
Fiscal Period
July . . . . . . . . . . . . . . . . .
August
. . . . . . . . . . . . . .
September . . . . . . . . . . . .
—
1,600,861
1,313,690
Total
. . . . . . . . . . . . . .
2,914,551
$ —
63.96
62.88
$63.47
—
1,600,861
1,313,690
2,914,551
$627
524
442
$442
(a) All open market purchases during the quarter were made under the fiscal 2023 authorization from our
board of directors to purchase up to $1 billion of shares of common stock. See Note 9. Stockholders’
Equity.
Item 6. RESERVED
Item 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
Outlook
The Company is affected by general economic and industrial growth, raw material availability, cost
inflation, supply chain disruptions, and general consumption levels. Our business has both geographic and
end market diversity, which reduces the effect of any one of these factors on our overall performance. Our
results are affected by our ability to pass through raw material and other cost changes to our customers,
improve manufacturing productivity and adapt to volume changes of our customers. Despite global macro-
economic challenges in the short-term attributed to continued rising inflation and general market softness,
we continue to believe our underlying long-term fundamentals in all divisions remain strong. For fiscal 2024,
we project cash flow from operations between $1.35 to $1.45 billion and free cash flow between $800 to
$900 million. Projected fiscal 2024 free cash flow assumes $550 million of capital spending. For the definition
of free cash flow and further information related to free cash flow as a non-GAAP financial measure, see
“Liquidity and Capital Resources.”
Discussion of Results of Operations for Fiscal 2023 Compared to Fiscal 2022
The Company’s U.S. based results for fiscal 2023 and fiscal 2022 are based on fifty-two week periods.
Business integration expenses consist of restructuring and impairment charges, divestiture related costs, and
other business optimization costs. Tables present dollars in millions. A discussion and analysis regarding our
results of operations for fiscal year 2022 compared to fiscal year 2021 can be found on Form 10-K, filed with the
SEC in November 2022.
10
Consolidated Overview
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cost of goods sold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other operating expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fiscal Year
2023
2022
$ Change % Change
$12,664
10,354
1,231
$ 1,079
$14,495
12,123
1,130
$(1,831)
(1,769)
101
$ 1,242
$ (163)
(13)%
(15)%
9%
(13)%
Net sales: The net sales decline is primarily attributed to decreased selling prices of $856 million
primarily due to the pass-through of lower resin costs, a 6% volume decline, an $84 million unfavorable
impact from foreign currency changes, and fiscal 2022 divestiture sales of $107 million. The volume decline
is primarily attributed to general market softness and customer destocking.
Cost of goods sold: The cost of goods sold decrease is primarily attributed to lower raw material
prices, the volume decline, fiscal 2022 divestiture cost of goods sold, and an unfavorable impact from
foreign currency changes.
Other operating expenses: The other operating expenses increase is primarily attributed to an increase
in business integration costs and incentive-based compensation.
Operating Income: The operating income decrease is primarily attributed to a $134 million unfavorable
impact from the volume decline, a $79 million unfavorable impact from increased business integration costs,
a $33 million unfavorable impact from foreign currency changes, and a $49 million unfavorable impact
from increased selling, general, and administrative expenses primarily attributed to increased incentive-
based compensation. These declines are partially offset by a $139 million favorable impact from price cost
spread.
Consumer Packaging International
Fiscal Year
2023
2022
$ Change % Change
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$4,031
$ 273
$4,293
$ 346
$(262)
$ (73)
(6)%
(21)%
Net sales: The net sales decline is primarily attributed to a 5% volume decline, fiscal 2022 divestiture
sales of $107 million, and a $60 million unfavorable impact from foreign currency changes, partially offset
by increased selling prices of $102 million due to the pass-through of European inflation. The volume decline
is primarily attributed to general market softness.
Operating Income: The operating income decrease is primarily attributed to a $39 million unfavorable
impact from increased business integration costs, a $36 million unfavorable impact from the volume decline,
a $17 million unfavorable impact from foreign currency changes, an unfavorable impact from increased
selling, general, and administrative expenses, and an unfavorable impact from fiscal 2022 divestiture. These
declines were partially offset by a $44 million favorable impact from price cost spread.
Consumer Packaging North America
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fiscal Year
2023
2022
$ Change % Change
$3,122
$ 346
$3,548
$ 338
$(426)
$
8
(12)%
2%
Net sales: The net sales decline is primarily attributed to decreased selling prices of $344 million and
a 3% volume decline. The volume decline is primarily attributed to general market softness partially offset
by growth in our foodservice market.
11
Operating Income: The operating income increase is primarily attributed to a $67 million favorable
impact from price cost spread, partially offset by a $21 million unfavorable impact from the volume decline,
an $18 million unfavorable impact from increased business integration costs, and an unfavorable impact
from increased selling, general, and administrative expenses.
Engineered Materials
Fiscal Year
2023
2022
$ Change % Change
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$2,884
$ 333
$3,488
$ 328
$(604)
5
$
(17)%
2%
Net sales: The net sales decline is primarily attributed to decreased selling prices of $292 million, an
8% volume decline, and a $31 million unfavorable impact from foreign currency changes. The volume decline
is primarily attributed to general market softness and destocking.
Operating Income: The operating income increase is primarily attributed to an $81 million favorable
impact from price cost spread, partially offset by a $48 million unfavorable impact from the volume decline,
and an unfavorable impact from increased selling, general, and administrative expenses.
Health, Hygiene & Specialties
Fiscal Year
2023
2022
$ Change % Change
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$2,627
$ 127
$3,166
$ 230
$(539)
$(103)
(17)%
(45)%
Net sales: The net sales decline is primarily attributed to decreased selling prices of $322 million and
a 7% volume decline. The volume decline is primarily attributed to general market softness and customer
destocking.
Operating Income: The operating income decrease is primarily attributed to a $52 million unfavorable
impact from price cost spread, a $30 million unfavorable impact from the volume decline, and an unfavorable
impact from increased business integration costs.
Other expense
Other expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$31
$22
$9
41%
The Other expense increase is primarily attributed to an adverse impact from our hyperinflationary
Fiscal Year
2023
2022
$ Change % Change
Argentina subsidiaries.
Interest expense
Fiscal Year
2023
2022
$ Change % Change
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$306
$286
$20
7%
The interest expense increase is primarily the result of higher interest rates partially offset by an
increased benefit from the amortization of settled interest rate swaps in fiscal 2022.
Comprehensive Income
Comprehensive Income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$676
$659
$17
3%
Fiscal Year
2023
2022
$ Change % Change
12
The increase in comprehensive income is primarily attributed to a $416 million favorable change in
currency translation, partially offset by a $157 million decrease in net income, a $155 million unfavorable
change in the fair value of interest rate hedges, and an $87 million unfavorable change from unrealized losses
on the Company’s pension plans. Currency translation changes are primarily related to non-U.S. subsidiaries
with a functional currency other than the U.S. dollar whereby assets and liabilities are translated from the
respective functional currency into U.S. dollars using period-end exchange rates. The change in currency
translation was primarily attributed to locations utilizing the euro and British pound sterling as their functional
currency. As part of the overall risk management, the Company uses derivative instruments to (i) reduce
our exposure to changes in interest rates attributed to the Company’s borrowings and (ii) reduce foreign
currency exposure to translation of certain foreign operations. The Company records changes to the fair value
of these instruments in Accumulated other comprehensive income (loss). The change in fair value of these
instruments in fiscal 2023 versus fiscal 2022 is primarily attributed to a change in the forward interest and
foreign exchange curves between measurement dates.
Liquidity and Capital Resources
Senior Secured Credit Facility
We manage our global cash requirements considering (i) available funds among the many subsidiaries
through which we conduct our business, (ii) the geographic location of our liquidity needs, and (iii) the cost
to access international cash balances. At the end of fiscal 2023, the Company had no outstanding balance
on its $1.0 billion asset-based revolving line of credit that matures in June 2028. The Company was in
compliance with all covenants at the end of fiscal 2023. See Note 3. Long-Term Debt.
Cash Flows from Operating Activities
Net cash provided by operating activities increased $52 million from fiscal 2022 primarily attributed to
working capital improvement, partially offset by a decline in net income and derivative settlements.
Cash Flows from Investing Activities
Net cash used in investing activities increased $293 million from fiscal 2022 primarily attributed to the
acquisition of Pro-Western in fiscal 2023 compared to the proceeds from business divestitures and the
settlement of net investment hedges in fiscal 2022. See Note 2. Acquisition.
Cash Flows from Financing Activities
Net cash used in financing activities increased $367 million from fiscal 2022 primarily attributed to
higher net repayments on long-term borrowings and initiation of a quarterly dividend in fiscal 2023,
partially offset by lower share repurchases.
Dividends
The Company declared and paid cash dividends of $127 million during fiscal 2023.
Share Repurchases
The Company repurchased approximately 9.8 million shares for $601 million and approximately
12.2 million shares for $709 million in fiscal 2023 and fiscal 2022, respectively. See Note 9. Stockholders’
Equity.
Free Cash Flow
We define “free cash flow” as cash flow from operating activities less net additions to property, plant
and equipment. Based on our definition, our consolidated free cash flow is summarized as follows:
13
Cash flow from operating activities
. . . . . . . . . . . . . . . . . . . . . . . . . .
Additions to property, plant and equipment, net . . . . . . . . . . . . . . . . .
Free cash flow . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fiscal years ended
September 30,
2023
October 1,
2022
$1,615
(689)
$ 926
$1,563
(687)
$ 876
We use free cash flow as a supplemental measure of liquidity as it assists us in assessing our ability to
fund growth through generation of cash. Free cash flow may be calculated differently by other companies,
including other companies in our industry or peer group, limiting its usefulness. Free cash flow is not a
generally accepted accounting principles (“GAAP’) financial measure and should not be considered as an
alternative to any other measure determined in accordance with GAAP.
Liquidity Outlook
At the end of fiscal 2023, our cash balance was $1,203 million, of which approximately 45% was
located outside the U.S. We believe our existing U.S. based cash and cash flow from U.S. operations,
together with available borrowings under our senior secured credit facilities, will be adequate to meet our
short-term and long-term liquidity needs with the exception of funds needed to cover all long-term debt
obligations which we intend to refinance prior to maturity. The Company has the ability to repatriate the cash
located outside the U.S. to the extent not needed to meet operational and capital needs without significant
restrictions. Our unremitted foreign earnings were $1.6 billion at the end of fiscal 2023. The computation of
the deferred tax liability associated with unremitted earnings is not practicable.
Summarized Guarantor Financial Information
Berry Global, Inc. (“Issuer”) has notes outstanding which are fully, jointly, severally, and unconditionally
guaranteed by its parent, Berry Global Group, Inc. (for purposes of this section, “Parent”) and substantially
all of Issuer’s domestic subsidiaries. Separate narrative information or financial statements of the guarantor
subsidiaries have not been included because they are 100% owned by Parent and the guarantor subsidiaries
unconditionally guarantee such debt on a joint and several basis. A guarantee of a guarantor subsidiary of the
securities will terminate upon the following customary circumstances: the sale of the capital stock of such
guarantor if such sale complies with the indentures, the designation of such guarantor as an unrestricted
subsidiary, the defeasance or discharge of the indenture or in the case of a restricted subsidiary that is required
to guarantee after the relevant issuance date, if such guarantor no longer guarantees certain other
indebtedness of the issuer. The guarantees of the guarantor subsidiaries are also limited as necessary to
prevent them from constituting a fraudulent conveyance under applicable law and any guarantees guaranteeing
subordinated debt are subordinated to certain other of the Company’s debts. Parent also guarantees the
Issuer’s term loans and revolving credit facilities. The guarantor subsidiaries guarantee our term loans and
are co-borrowers under our revolving credit facility.
Presented below is summarized financial information for the Parent, Issuer and guarantor subsidiaries
on a combined basis, after intercompany transactions have been eliminated.
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross profit
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Earnings from continuing operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income(a)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Year Ended
September 30,
2023
$6,660
1,611
410
$ 410
(a)
Includes $39 million of income associated with intercompany activity with non-guarantor subsidiaries.
14
September 30,
2023
October 1,
2022
Assets
Current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Noncurrent assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Liabilities
$ 1,975
5,997
$ 2,432
6,137
Current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intercompany payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Noncurrent liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 1,363
754
10,271
$ 1,536
634
10,630
Critical Accounting Estimates
We disclose those accounting policies that we consider to be significant in determining the amounts to
be utilized for communicating our consolidated financial position, results of operations and cash flows in
the first note to our consolidated financial statements included elsewhere herein. Our discussion and analysis
of our financial condition and results of operations are based on our consolidated financial statements,
which have been prepared in accordance with GAAP. The preparation of financial statements in conformity
with these principles requires management to make estimates and assumptions that affect amounts reported
in the financial statements and accompanying notes. Actual results may differ from these estimates under
different assumptions or conditions.
Pensions. The accounting for our pension plans requires us to recognize the overfunded or
underfunded status of the pension plans on our balance sheet. We believe that the accounting estimates
related to our pension plans are critical accounting estimates because they are highly susceptible to change
from period to period based on the performance of plan assets, actuarial valuations, market conditions and
contracted benefit changes. See Note 1. Basis of Presentation and Summary of Significant Accounting
Policies and Note 7. Retirement Plans.
Deferred Taxes and Effective Tax Rates. We estimate the effective tax rate (“ETR”) and associated
liabilities or assets for each of our legal entities in accordance with authoritative guidance. We utilize tax
planning to minimize or defer tax liabilities to future periods. In recording ETRs and related liabilities and
assets, we rely upon estimates, which are based upon our interpretation of U.S. and local tax laws as they apply
to our legal entities and our overall tax structure. Audits by local tax jurisdictions, including the U.S.
Government, could yield different interpretations from our own and cause the Company to owe more taxes
than originally recorded. See Note 1. Basis of Presentation and Summary of Significant Accounting
Policies and Note 6. Income Taxes.
Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Interest Rate Risk
We are exposed to market risk from changes in interest rates primarily through our senior secured
credit facilities and accounts receivable supply chain finance factoring programs. As of September 30, 2023,
our senior secured credit facilities are comprised of (i) $3.1 billion term loans and (ii) a $1.0 billion revolving
credit facility with no borrowings outstanding. Borrowings under our senior secured credit facilities bear
interest at a rate equal to an applicable margin plus SOFR. The applicable margin for SOFR rate borrowings
under the revolving credit facility ranges from 1.25% to 1.50%, and the margin for the term loans is 1.75% per
annum. As of September 30, 2023, the SOFR rate of approximately 5.54% was applicable to the term
loans. A change of 0.25% on these floating interest rate exposures would increase interest expense by
approximately $2 million.
We seek to minimize interest rate volatility risk through regular operating and financing activities and,
when deemed appropriate, through the use of derivative financial instruments. These financial instruments
are not used for trading or other speculative purposes. See Note 4. Financial Instruments and Fair Value
Measurements.
15
Foreign Currency Risk
As a global company, we face foreign currency risk exposure from fluctuating currency exchange rates,
primarily the U.S. dollar against the euro, British pound sterling, Brazilian real, Chinese renminbi, Canadian
dollar and Mexican peso. Significant fluctuations in currency rates can have a substantial impact, either
positive or negative, on our revenue, cost of sales, and operating expenses. Currency translation gains and
losses are primarily related to non-U.S. subsidiaries with a functional currency other than U.S. dollars whereby
assets and liabilities are translated from the respective functional currency into U.S. dollars using period-
end exchange rates and impact our Comprehensive income. A 10% decline in foreign currency exchange rates
would have had a $31 million unfavorable impact on fiscal 2023 Net income. See Note 4. Financial
Instruments and Fair Value Measurements.
16
Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Report of Independent Registered Public Accounting Firm
To the Stockholders and the Board of Directors of Berry Global Group, Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Berry Global Group, Inc. (the
Company) as of September 30, 2023 and October 1, 2022, the related consolidated statements of income,
comprehensive income, changes in stockholders’ equity and cash flows for each of the three years in the
period ended September 30, 2023, and the related notes (collectively referred to as the “consolidated financial
statements”). In our opinion, the consolidated financial statements present fairly, in all material respects,
the financial position of the Company at September 30, 2023 and October 1, 2022, and the results of its
operations and its cash flows for each of the three years in the period ended September 30, 2023, in conformity
with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight
Board (United States) (PCAOB), the Company’s internal control over financial reporting as of September 30,
2023, based on criteria established in Internal Control — Integrated Framework issued by the Committee
of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated
November 17, 2023 expressed an unqualified opinion thereon.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is
to express an opinion on the Company’s financial statements based on our audits. We are a public accounting
firm registered with the PCAOB and are required to be independent with respect to the Company in
accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities
and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require
that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud. Our audits included performing procedures
to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and
performing procedures that respond to those risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the financial statements. Our audits also included
evaluating the accounting principles used and significant estimates made by management, as well as
evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable
basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the
financial statements that was communicated or required to be communicated to the audit committee and
that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our
especially challenging, subjective or complex judgments. The communication of the critical audit matter does
not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are
not, by communicating the critical audit matter below, providing a separate opinion on the critical audit
matter or on the account or disclosures to which it relates.
United Kingdom Defined Benefit Pension Obligation
Description of the
Matter
At September 30, 2023 the aggregate United Kingdom (UK) defined benefit pension
obligation was $505 million. As disclosed in Notes 1 and 7 to the consolidated
financial statements, the obligation for these plans are actuarially determined and
affected by assumptions, including discount rates and mortality rates.
17
How We Addressed
the Matter in Our
Audit
Auditing the UK defined benefit pension obligation is complex and required the
involvement of our actuarial specialists due to the highly judgmental nature of
actuarial assumptions (e.g., discount rates and mortality rates) used in the
measurement process. These assumptions have a significant effect on the projected
benefit obligation.
We obtained an understanding, evaluated the design and tested the operating
effectiveness of controls that address the measurement and valuation of the UK
defined benefit pension obligation. This included management’s review of the UK
defined benefit pension obligation calculations and the significant actuarial
assumptions used by management.
To test the UK defined benefit pension obligation, we performed audit procedures
that included, among others, evaluating the methodology used and the significant
actuarial assumptions described above. We involved our actuarial specialists to assist
with our audit procedures. We compared the actuarial assumptions used by
management to historical trends and evaluated the change in the defined benefit
pension obligation from prior year due to the change in service cost, interest cost,
actuarial gains and losses, benefit payments, contributions and other activities. In
addition, we evaluated management’s methodology for determining the discount rate
that reflects the maturity and duration of the benefit payments and is used to
measure the defined benefit pension obligation. As part of this assessment, we
compared management’s selected discount rate to an independently developed range
of reasonable discount rates. To evaluate the mortality rate assumption, we assessed
whether the information is consistent with publicly available information, and
whether any market data adjusted for entity-specific factors were applied.
/s/ Ernst & Young LLP
We have served as the Company’s auditor since 1991.
Indianapolis, Indiana
November 17, 2023
18
Report of Independent Registered Public Accounting Firm
To the Stockholders and the Board of Directors of Berry Global Group, Inc.
Opinion on Internal Control Over Financial Reporting
We have audited Berry Global Group, Inc.’s internal control over financial reporting as of September 30,
2023, based on criteria established in Internal Control — Integrated Framework issued by the Committee
of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our
opinion, Berry Global Group, Inc. (the Company) maintained, in all material respects, effective internal control
over financial reporting as of September 30, 2023, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight
Board (United States) (PCAOB), the consolidated balance sheets of the Company as of September 30, 2023
and October 1, 2022, the related consolidated statements of income, comprehensive income, changes in
stockholders’ equity and cash flows for each of the three years in the period ended September 30, 2023, and
the related notes and our report dated November 17, 2023 expressed an unqualified opinion thereon.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial
reporting and for its assessment of the effectiveness of internal control over financial reporting included in
the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is
to express an opinion on the Company’s internal control over financial reporting based on our audit. We
are a public accounting firm registered with the PCAOB and are required to be independent with respect to
the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations
of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that
we plan and perform the audit to obtain reasonable assurance about whether effective internal control over
financial reporting was maintained in all material respects.
Our audit included obtaining an understanding of internal control over financial reporting, assessing
the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of
internal control based on the assessed risk, and performing such other procedures as we considered necessary
in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles. A company’s internal control
over financial reporting includes those policies and procedures that (1) pertain to the maintenance of
records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets
of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted accounting principles, and that
receipts and expenditures of the company are being made only in accordance with authorizations of
management and directors of the company; and (3) provide reasonable assurance regarding prevention or
timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a
material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk
that controls may become inadequate because of changes in conditions, or that the degree of compliance with
the policies or procedures may deteriorate.
/s/ Ernst & Young LLP
Indianapolis, Indiana
November 17, 2023
19
BERRY GLOBAL GROUP, INC.
CONSOLIDATED STATEMENTS OF INCOME
(in millions of dollars)
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Costs and expenses:
Cost of goods sold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling, general and administrative . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
Restructuring and transaction activities
Operating income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income tax expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income per share (see Note 11):
Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Fiscal years ended
September 30,
2023
October 1,
2022
October 2,
2021
$12,664
$14,495
$13,850
10,354
886
243
102
1,079
31
306
742
133
609
5.07
4.95
$
$
$
12,123
850
257
23
1,242
22
286
934
168
766
5.87
5.77
$
$
$
11,352
867
288
51
1,292
51
336
905
172
733
5.45
5.30
$
$
$
See notes to consolidated financial statements.
20
BERRY GLOBAL GROUP, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in millions of dollars)
Fiscal years ended
September 30,
2023
October 1,
2022
October 2,
2021
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Currency translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pension and postretirement benefits . . . . . . . . . . . . . . . . . . . . . . .
Derivative instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive (loss) income . . . . . . . . . . . . . . . . . . . . . . . . .
Comprehensive income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$609
115
(52)
4
67
$676
$ 766
(301)
35
159
(107)
$ 659
$733
124
49
82
255
$988
See notes to consolidated financial statements.
21
BERRY GLOBAL GROUP, INC.
CONSOLIDATED BALANCE SHEETS
(in millions of dollars)
September 30,
2023
October 1,
2022
Assets
Current assets:
Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accounts receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid expenses and other current assets . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Property, plant and equipment
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill and intangible assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Right-of-use assets
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 1,203
1,568
1,557
205
4,533
4,576
6,684
625
169
$ 1,410
1,777
1,802
175
5,164
4,342
6,685
521
244
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$16,587
$16,956
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued employee costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current portion of long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Employee benefit obligations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating lease liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other long-term liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 1,528
273
902
10
2,713
8,970
573
193
525
397
$ 1,795
253
783
13
2,844
9,242
707
160
429
378
Total liabilities
Stockholders’ equity:
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Common stock (115.5 and 124.2 shares issued, respectively) . . . . . . . . . . . . . .
Additional paid-in capital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Retained earnings
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total stockholders’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
13,371
13,760
1
1,231
2,320
(336)
3,216
1
1,177
2,421
(403)
3,196
Total liabilities and stockholders’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$16,587
$16,956
See notes to consolidated financial statements.
22
BERRY GLOBAL GROUP, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions of dollars)
Cash Flows from Operating Activities:
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Adjustments to reconcile net cash from operating activities:
Depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-cash interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Share-based compensation expense . . . . . . . . . . . . . . . . . . . . . . .
Deferred income tax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other non-cash operating activities, net
. . . . . . . . . . . . . . . . . . . .
Settlement of derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Changes in operating assets and liabilities:
Accounts receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid expenses and other assets . . . . . . . . . . . . . . . . . . . . . . .
Accounts payable and other liabilities . . . . . . . . . . . . . . . . . . . .
Net cash from operating activities . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash Flows from Investing Activities:
Additions to property, plant and equipment, net . . . . . . . . . . . . . . . .
Acquisition of businesses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Divestiture of businesses
. . . . . . . . . . . . . . . . . . . . . . . .
Settlement of net investment hedges
Net cash from investing activities . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash Flows from Financing Activities:
Proceeds from long-term borrowings . . . . . . . . . . . . . . . . . . . . . . . .
Repayment of long-term borrowings . . . . . . . . . . . . . . . . . . . . . . . .
Proceeds from issuance of common stock . . . . . . . . . . . . . . . . . . . . .
Repurchase of common stock . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dividends paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Debt financing costs
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net cash from financing activities . . . . . . . . . . . . . . . . . . . . . . . . . .
Effect of currency translation on cash . . . . . . . . . . . . . . . . . . . . . . .
Net change in cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . .
Cash and cash equivalents at beginning of period . . . . . . . . . . . . . . .
Fiscal years ended
September 30,
2023
October 1,
2022
October 2,
2021
$
609
$ 766
$
733
575
243
(61)
42
(117)
22
36
294
343
1
(372)
562
257
6
39
(48)
(22)
201
(86)
(3)
11
(120)
566
288
32
40
(73)
49
—
(331)
(639)
(30)
945
1,615
1,563
1,580
(689)
(87)
—
—
(776)
496
(869)
36
(601)
(127)
(6)
(1,071)
25
(207)
1,410
(687)
—
128
76
(483)
—
(22)
27
(709)
—
—
(704)
(57)
319
1,091
(676)
—
165
—
(511)
2,716
(3,496)
60
—
—
(21)
(741)
13
341
750
Cash and cash equivalents at end of period . . . . . . . . . . . . . . . . . . . .
$ 1,203
$1,410
$ 1,091
See notes to consolidated financial statements.
23
BERRY GLOBAL GROUP, INC.
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(in millions of dollars)
Common
Stock
Additional
Paid-in Capital
Accumulated Other
Comprehensive Loss
Retained
Earnings
Balance at September 26, 2020 . . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income . . . . . . . . . . .
Share-based compensation . . . . . . . . . . . .
Proceeds from issuance of common stock . .
Balance at October 2, 2021 . . . . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive loss . . . . . . . . . . . . .
Share-based compensation . . . . . . . . . . . .
Proceeds from issuance of common stock . .
Common stock repurchased and retired . . .
Balance at October 1, 2022 . . . . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . . . .
Other comprehensive income . . . . . . . . . . .
Share-based compensation . . . . . . . . . . . .
Proceeds from issuance of common stock . .
Common stock repurchased, retired and
other . . . . . . . . . . . . . . . . . . . . . . . . . .
Dividends paid . . . . . . . . . . . . . . . . . . . . .
Balance at September 30, 2023 . . . . . . . . . .
$ 1
—
—
—
—
$ 1
—
—
—
—
—
$ 1
—
—
—
—
—
—
$ 1
$1,034
—
—
40
60
$1,134
—
—
39
27
(23)
$1,177
—
—
42
36
(24)
—
$(551)
—
255
—
—
$(296)
—
(107)
—
—
—
$(403)
—
67
—
—
—
—
Total
$2,092
733
255
40
60
$3,180
766
(107)
39
27
(709)
$3,196
609
67
42
36
$1,608
733
—
—
—
$2,341
766
—
—
—
(686)
$2,421
609
—
—
—
(583)
(127)
(607)
(127)
$1,231
$(336)
$2,320
$3,216
See notes to consolidated financial statements.
24
BERRY GLOBAL GROUP, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in millions of dollars, except as otherwise noted)
1. Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation
Berry Global Group, Inc.’s (“Berry,” “we,” or the “Company”) consolidated financial statements have
been prepared in accordance with accounting principles generally accepted in the U.S. (“GAAP”) pursuant
to the rules and regulations of the Securities and Exchange Commissions. Periods presented in these
financial statements include fiscal periods ending September 30, 2023 (“fiscal 2023”), October 1, 2022
(“fiscal 2022”), and October 2, 2021 (“fiscal 2021”). The Company’s U.S. based results for fiscal 2023 and
fiscal 2022 are based on a fifty-two week period. Fiscal 2021 was based on a fifty-three week period. The
Company has evaluated subsequent events through the date the financial statements were issued.
The consolidated financial statements include the accounts of Berry and its subsidiaries, all of which
includes our wholly owned and majority owned subsidiaries. The Company has certain foreign subsidiaries
that report on a calendar period basis which we consolidate into our respective fiscal period. Intercompany
accounts and transactions have been eliminated in consolidation.
During fiscal 2023, the Company announced that it has initiated a formal process to evaluate strategic
alternatives for its Health, Hygiene and Specialties segment and has determined the segment does not meet
the criteria of Held for Sale as of year end.
Revenue Recognition and Accounts Receivable
Our revenues are primarily derived from the sale of non-woven, flexible and rigid products. Revenue is
recognized when performance obligations are satisfied, in an amount reflecting the consideration to which
the Company expects to be entitled. We consider the promise to transfer products to be our sole performance
obligation. If the consideration agreed to in a contract includes a variable amount, we estimate the amount
of consideration we expect to be entitled to in exchange for transferring the promised goods to the customer
using the most likely amount method. Our main sources of variable consideration are customer rebates. There
are no material instances where variable consideration is constrained and not recorded at the initial time of
sale. Generally, our revenue is recognized at a point in time for standard promised goods at the time of
shipment, when title and risk of loss pass to the customer. The accrual for customer rebates was $106 million
and $103 million at September 30, 2023 and October 1, 2022, respectively, and is included in Other current
liabilities on the Consolidated Balance Sheets. The Company disaggregates revenue based on reportable
business segment, geography, and significant product line. See Note 10. Segment and Geographic Data.
Accounts receivable are presented net of allowance for credit losses of $19 million and $18 million at
September 30, 2023 and October 1, 2022, respectively. The Company records current expected credit losses
based on a variety of factors including historical loss experience and current customer financial condition.
The changes to our current expected credit losses, write-off activity, and recoveries were not material for
any of the periods presented.
The Company has entered into various factoring agreements, primarily customer-based supply chain
financing programs, to sell certain receivables to third-party financial institutions. Agreements which result
in true sales of the transferred receivables, which occur when receivables are transferred without recourse to
the Company, are reflected as a reduction of trade receivables, net on the consolidated balance sheets and
the proceeds are included in the cash flows from operating activities in the consolidated statements of cash
flows.
Research and Development
Research and development costs are expensed when incurred. The Company incurred research and
development expenditures of $82 million, $81 million, and $90 million in fiscal 2023, 2022, and 2021,
respectively.
25
Share-Based Compensation
The Company recognized total share-based compensation expense of $42 million, $39 million, and
$40 million for fiscal 2023, 2022, and 2021, respectively. The share-based compensation plan is more fully
described in Note 9. Stockholders’ Equity.
Foreign Currency
For the non-U.S. subsidiaries that account in a functional currency other than U.S. dollars, assets and
liabilities are translated into U.S. dollars using period-end exchange rates. Sales and expenses are translated
at the average exchange rates in effect during the period. Foreign currency translation gains and losses are
included as a component of Accumulated other comprehensive loss within Stockholders’ equity. Gains and
losses resulting from foreign currency transactions are included in the Consolidated Statements of Income.
Cash and Cash Equivalents
All highly liquid investments purchased with a maturity of three months or less from the time of
purchase are considered to be cash equivalents.
Inventories
Inventories are stated at the lower of cost or net realizable value and are valued using the first-in, first-
out method. Management periodically reviews inventory balances, using recent and future expected sales to
identify slow-moving and/or obsolete items. The cost of spare parts is charged to cost of goods sold when
purchased. We evaluate our reserve for inventory obsolescence on a quarterly basis and review inventory on-
hand to determine future salability. We base our determinations on the age of the inventory and the
experience of our personnel. We reserve inventory that we deem to be not salable in the quarter in which we
make the determination. We believe, based on past history and our policies and procedures, that our net
inventory is salable. Inventory as of fiscal 2023 and 2022 was:
Inventories:
Finished goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Raw materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2023
2022
$ 933
624
$1,557
$1,010
792
$1,802
Property, Plant and Equipment
Property, plant and equipment are stated at cost. Depreciation is computed primarily by the straight-
line method over the estimated useful lives of the assets ranging from 15 to 40 years for buildings and
improvements, 2 to 20 years for machinery, equipment, and tooling, and over the term of the agreement for
capital leases. Leasehold improvements are depreciated over the shorter of the useful life of the
improvement or the lease term. Repairs and maintenance costs are charged to expense as incurred. Property,
plant and equipment as of fiscal 2023 and 2022 was:
Property, plant and equipment:
Land, buildings and improvements
. . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 1,693
$ 1,602
2023
2022
Equipment and construction in progress . . . . . . . . . . . . . . . . . . . . . . . . .
Less accumulated depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7,570
9,263
(4,687)
6,916
8,518
(4,176)
$ 4,576
$ 4,342
26
Long-lived Assets
Long-lived assets, including property, plant and equipment and definite lived intangible assets are
reviewed for impairment in accordance with ASC 360, “Property, Plant and Equipment,” whenever facts
and circumstances indicate that the carrying amount may not be recoverable. Specifically, this process involves
comparing an asset’s carrying value to the estimated undiscounted future cash flows the asset is expected
to generate over its remaining life. If this process were to result in the conclusion that the carrying value of
a long-lived asset would not be recoverable, a write-down of the asset to fair value would be recorded through
a charge to operations.
Goodwill
The changes in the carrying amount of goodwill by reportable segment are as follows:
Balance as of fiscal 2021 . . . . . . . . . . . . . . . .
Foreign currency translation adjustment . . . . .
Dispositions . . . . . . . . . . . . . . . . . . . . . . . .
Balance as of fiscal 2022 . . . . . . . . . . . . . . . .
Foreign currency translation adjustment . . . . .
. . . . . .
Pro-Western acquisition (See Note 2.)
Balance as of fiscal 2023 . . . . . . . . . . . . . . . .
Consumer
Packaging
International
$2,016
(250)
(54)
$1,712
81
—
$1,793
Consumer
Packaging
North America
$1,541
(1)
—
$1,540
1
38
$1,579
Engineered
Materials
$699
(37)
—
$662
17
—
$679
Health,
Hygiene &
Specialties
$936
(18)
—
$918
12
—
$930
Total
$5,192
(306)
(54)
$4,832
111
38
$4,981
In fiscal year 2023, the Company completed a qualitative analysis to evaluate impairment of goodwill
and concluded that it was more likely than not that the fair value for each reporting unit exceeded the carrying
amount. We reached this conclusion based on the stable valuations within the packaging industry and
operating results of our reporting units, in addition to value indications provided from third parties related
to the Company’s evaluation of strategic alternatives for the Health, Hygiene & Specialties segment. As a
result of our annual impairment evaluations the Company concluded that no impairment existed in fiscal
2023.
Deferred Financing Fees
Deferred financing fees are amortized to interest expense using the effective interest method over the
lives of the respective debt agreements. Pursuant to ASC 835-30, the Company presents $34 million and
$60 million as of fiscal 2023 and fiscal 2022, respectively, of debt issuance and deferred financing costs on
the balance sheet as a deduction from the carrying amount of the related debt liability, instead of a deferred
charge.
Intangible Assets
The changes in the carrying amount of intangible assets are as follows:
Balance as of fiscal 2021 . . . . . . . . . . . . . . . .
Foreign currency translation adjustment . . . . .
Amortization expense . . . . . . . . . . . . . . . . . .
Additions
. . . . . . . . . . . . . . . . . . . . . . . . . .
Balance as of fiscal 2022 . . . . . . . . . . . . . . . .
Foreign currency translation adjustment . . . . .
Amortization expense . . . . . . . . . . . . . . . . . .
Pro-Western acquisition (See Note 2.) . . . . . . .
Balance as of fiscal 2023 . . . . . . . . . . . . . . . .
Trademarks
$525
(31)
—
—
$494
12
—
3
$509
Other
Intangibles
$122
(1)
—
6
$127
1
—
—
$128
Accumulated
Amortization
$(1,734)
66
(257)
—
$(1,925)
(27)
(243)
—
$(2,195)
Total
$2,242
(138)
(257)
6
$1,853
55
(243)
38
$1,703
Customer
Relationships
$3,329
(172)
—
—
$3,157
69
—
35
$3,261
27
Customer relationships are being amortized using an accelerated amortization method which
corresponds with the customer attrition rates used in the initial valuation of the intangibles over the
estimated life of the relationships which range from 5 to 17 years. Definite lived trademarks are being
amortized using the straight-line method over the estimated life of the assets which are not more than
15 years. Other intangibles, which include technology and licenses, are being amortized using the straight-
line method over the estimated life of the assets which range from 5 to 14 years. The Company has trademarks
that total $248 million that are indefinite lived and we test annually for impairment on the first day of the
fourth quarter. We completed the annual impairment test of our indefinite lived trade names utilizing the
qualitative method in 2023, 2022, and 2021 and noted no impairment.
Future amortization expense for definite lived intangibles as of fiscal 2023 for the next five fiscal years
is $232 million, $219 million, $204 million, $171 million, and $147 million each year for fiscal years ending
2024, 2025, 2026, 2027, and 2028, respectively.
Insurable Liabilities
The Company records liabilities for the self-insured portion of workers’ compensation, health, product,
general and auto liabilities. The determination of these liabilities and related expenses is dependent on claims
experience. For most of these liabilities, claims incurred but not yet reported are estimated based upon
historical claims experience.
Leases
The Company leases certain manufacturing facilities, warehouses, office space, manufacturing
equipment, office equipment, and automobiles. We recognize right-of-use assets and lease liabilities for
leases with original lease terms greater than one year based on the present value of lease payments over the
lease term using our incremental borrowing rate on a collateralized basis. Short-term leases, with original lease
terms of less than one year, are not recognized on the balance sheet. We are party to certain leases, namely
for manufacturing facilities, which offer renewal options to extend the original lease term. Renewal options are
included in the right-of-use asset and lease liability based on our assessment of the probability that the
options will be exercised. See Note 5. Commitments, Leases and Contingencies.
At September 30, 2023, annual lease commitments were as follows:
Fiscal Year
2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2027 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2028 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total lease payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less: Interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Present value of lease liabilities
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating
Leases
Finance
Leases
$ 117
106
95
83
70
311
782
(141)
$10
7
9
1
1
3
31
(3)
$ 641
$28
Income Taxes
The Company accounts for income taxes under the asset and liability approach, which requires the
recognition of deferred tax assets and liabilities for the expected future tax consequence of events that have
been recognized in the Company’s financial statements or income tax returns. Income taxes are recognized
during the period in which the underlying transactions are recorded. Deferred taxes, with the exception of non-
deductible goodwill, are provided for temporary differences between amounts of assets and liabilities as
recorded for financial reporting purposes and such amounts as measured by tax laws. If the Company
determines that a deferred tax asset arising from temporary differences is not likely to be utilized, the Company
28
will establish a valuation allowance against that asset to record it at its expected realizable value. The
Company recognizes uncertain tax positions when it is more likely than not that the tax position will be
sustained upon examination by relevant taxing authorities, based on the technical merits of the position. The
amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being
realized upon ultimate settlement. The Company’s effective tax rate is dependent on many factors including:
the impact of enacted tax laws in jurisdictions in which the Company operates; the amount of earnings by
jurisdiction, due to varying tax rates in each country; and the Company’s ability to utilize foreign tax credits
related to foreign taxes paid on foreign earnings that will be remitted to the U.S.
Comprehensive Income (Loss)
Comprehensive income (loss) is comprised of net income and other comprehensive income (loss).
Other comprehensive income (loss) includes net unrealized gains or losses resulting from currency translations
of foreign subsidiaries, changes in the value of our derivative instruments and adjustments to the pension
liability.
The accumulated balances related to each component of other comprehensive income (loss), net of tax
before reclassifications were as follows:
Currency
Translation
Defined Benefit
Pension and Retiree
Health Benefit Plans
Derivative
Instruments
Accumulated Other
Comprehensive Loss
Balance as of fiscal 2020 . . . . . . . . . . . . . . .
. . . . . . .
Other comprehensive income (loss)
Net amount reclassified from accumulated
other comprehensive income (loss) . . . . . .
Balance as of fiscal 2021 . . . . . . . . . . . . . . .
. . . . . . .
Other comprehensive income (loss)
Net amount reclassified from accumulated
other comprehensive income (loss) . . . . . .
Balance as of fiscal 2022 . . . . . . . . . . . . . . .
. . . . . . .
Other comprehensive income (loss)
Net amount reclassified from accumulated
other comprehensive income (loss) . . . . . .
Balance as of fiscal 2023 . . . . . . . . . . . . . . .
$(278)
124
—
$(154)
(301)
—
$(455)
115
—
$(340)
Pension
$(116)
(5)
54
$ (67)
32
3
$ (32)
(53)
1
$ (84)
$(157)
70
12
$ (75)
158
1
$ 84
39
(35)
$ 88
$(551)
189
66
$(296)
(111)
4
$(403)
101
(34)
$(336)
The accounting for our pension plans requires us to recognize the overfunded or underfunded status of
the pension plans on our balance sheet. The selection of assumptions is based on historical trends and known
economic and market conditions at the time of valuation, as well as independent studies of trends performed
by our actuaries. Pension benefit costs include assumptions for the discount rate, mortality rate, retirement
age, and expected return on plan assets. Retiree medical plan costs include assumptions for the discount rate,
retirement age, and health-care-cost trend rates. We review annually the discount rate used to calculate the
present value of pension plan liabilities. The discount rate used at each measurement date is set based on a
high-quality corporate bond yield curve, derived based on bond universe information sourced from reputable
third-party indices, data providers, and rating agencies. In countries where there is no deep market in
corporate bonds, we have used a government bond approach to set the discount rate. In evaluating other
assumptions, the Company considers many factors, including an evaluation of expected return on plan assets
and the health-care-cost trend rates of other companies; historical assumptions compared with actual
results; an analysis of current market conditions and asset allocations; and the views of advisers.
Net Income Per Share
The Company calculates basic net income per share based on the weighted-average number of
outstanding common shares. The Company calculates diluted net income per share based on the weighted-
average number of outstanding common shares plus the effect of dilutive securities.
29
Use of Estimates
The preparation of the financial statements in conformity with U.S. generally accepted accounting
principles requires management to make extensive use of estimates and assumptions that affect the reported
amount of assets and liabilities and disclosure of contingent assets and liabilities and the reported amounts
of sales and expenses. Actual results could differ materially from these estimates. Changes in estimates are
recorded in results of operations in the period that the event or circumstances giving rise to such changes
occur.
Recently Issued Accounting Pronouncements
Reference Rate Reform
During fiscal 2023, the Company adopted ASU 2020-04, Reference Rate Reform — Facilitation of the
Effects of Reference Rate Reform on Financial Reporting (Topic 848). The Company’s adoption did not
result in a material change to our consolidated financial statements or disclosures.
2. Acquisition
Pro-Western Plastics
During fiscal 2023, the Company acquired Pro-Western Plastics Ltd. (“Pro-Western”), a leading
plastics injection molding company, for a purchase price of $87 million. The acquired business is operated
within the Consumer Packaging North America segment. To finance the purchase, the Company used existing
liquidity. The acquisition has been accounted for under the purchase method of accounting and accordingly,
the purchase price has been allocated to the identifiable assets and liabilities based on preliminary estimates
of fair value at the acquisition date. The results of Pro-Western have been included in the consolidated results
of the Company since the date of acquisition. The Company has recognized goodwill on this transaction
primarily as a result of expected cost synergies and expects goodwill to be deductible for tax purposes.
3. Long-Term Debt
Long-term debt consists of the following:
Facility
Term loan(a)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Revolving line of credit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
0.95% First Priority Senior Secured Notes(b) . . . . . . . . . . . . . . . . . . . February 2024
1.00% First Priority Senior Secured Notes(c)
1.57% First Priority Senior Secured Notes
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
Maturity Date
July 2026(d)
June 2028
July 2025
January 2026
4.875% First Priority Senior Secured Notes . . . . . . . . . . . . . . . . . . . .
July 2026
1.65% First Priority Senior Secured Notes
1.50% First Priority Senior Secured Notes(c)
5.50% First Priority Senior Secured Notes
. . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . .
January 2027
July 2027
April 2028
4.50% Second Priority Senior Secured Notes . . . . . . . . . . . . . . . . . . . February 2026
5.625% Second Priority Senior Secured Notes . . . . . . . . . . . . . . . . . .
July 2027
Debt discounts and deferred fees . . . . . . . . . . . . . . . . . . . . . . . . . . .
Finance leases and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Various
Total long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current portion of long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term debt, less current portion . . . . . . . . . . . . . . . . . . . . . . . .
30
2023
2022
$3,090
—
279
741
1,525
1,250
$3,440
—
800
686
1,525
1,250
400
397
500
291
500
(34)
41
400
367
—
298
500
(60)
49
8,980
(10)
9,255
(13)
$8,970
$9,242
(a) Effectively 88% fixed interest rate with interest rate swaps (see Note 4).
(b)
Indicates debt which has been classified as long-term debt in accordance with the Company’s ability
and intention to refinance such obligations on a long-term basis.
(c) Euro denominated
(d)
In October 2023, the Company extended the maturity date of $1,550 million of the Term Loans to
2029.
During fiscal 2023, the Company issued $500 million aggregate principal amount of 5.50% first
priority senior secured notes due 2028. The proceeds were used to repurchase a portion of the Company’s
0.95% first priority senior secured notes due 2024.
Debt discounts and deferred financing fees are presented net of Long-term debt, less the current
portion on the Consolidated Balance Sheets and are amortized to Interest expense on the Consolidated
Statements of Income through maturity.
Berry Global, Inc. Senior Secured Credit Facility
Our wholly owned subsidiary Berry Global, Inc.’s senior secured credit facilities consist of $3.1 billion
of term loans and a $1.0 billion asset-based revolving line of credit. The availability under the revolving line
of credit is the lesser of $1.0 billion or based on a defined borrowing base which is calculated based on
available accounts receivable and inventory. At the end of fiscal 2023, the Company had unused borrowing
capacity of $760 million under the revolving line of credit.
The term loan facility is payable upon maturity. The Company may voluntarily repay outstanding
loans under the senior secured credit facilities at any time without premium or penalty, other than customary
“breakage” costs with respect to eurodollar loans. All obligations under the senior secured credit facilities
are unconditionally guaranteed by the Company and, subject to certain exceptions, each of the Company’s
existing and future direct and indirect domestic subsidiaries. The guarantees of those obligations are secured
by substantially all of the Company’s assets as well as those of each domestic subsidiary guarantor.
Despite not having financial maintenance covenants, our debt agreements contain certain negative
covenants. We are in compliance with all covenants as of September 30, 2023. The failure to comply with
these negative covenants could restrict our ability to incur additional indebtedness, effect acquisitions, enter
into certain significant business combinations, make distributions or redeem indebtedness.
Future maturities of long-term debt as of fiscal year end 2023 are as follows:
Fiscal Year
Maturities
2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 289
2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2027 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2028 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
749
6,167
1,299
503
7
$9,014
Net cash interest was $377 million, $281 million, and $311 million in fiscal 2023, 2022, and 2021,
respectively.
4. Financial Instruments and Fair Value Measurements
In the normal course of business, the Company is exposed to certain risks arising from business
operations and economic factors. The Company may use derivative financial instruments to help manage
exposure to fluctuations in interest rates and foreign currencies. These financial instruments are not used for
31
trading or other speculative purposes. For those derivative instruments that are designated and qualify as
hedging instruments, the Company must designate the hedging instrument, based upon the exposure being
hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.
To the extent hedging relationships are found to be effective, changes in the fair value of the derivatives
are offset by changes in the fair value of the related hedged item and recorded to Accumulated other
comprehensive loss. Changes in the fair value of a derivative not designated as a hedge, are recorded to the
Consolidated Statements of Income.
Cross-Currency Swaps
The Company is party to certain cross-currency swaps to hedge a portion of our foreign currency risk.
The swap agreements mature June 2024 (€1,625 million) and July 2027 (£700 million). In addition to cross-
currency swaps, we hedge a portion of our foreign currency risk by designating foreign currency denominated
long-term debt as net investment hedges of certain foreign operations. As of September 30, 2023, we had
outstanding long-term debt of €379 million that was designated as a hedge of our net investment in certain
euro-denominated foreign subsidiaries. When valuing cross-currency swaps the Company utilizes Level 2
inputs (substantially observable).
Interest Rate Swaps
The primary purpose of the Company’s interest rate swap activities is to manage interest expense
fluctuations associated with our outstanding variable rate term loan debt. When valuing interest rate swaps
the Company utilizes Level 2 inputs (substantially observable).
During fiscal 2023, the Company elected to cash settle existing interest rate swaps and received net
proceeds of $36 million. The offset is included in Accumulated other comprehensive loss and is being
amortized to Interest expense through the term of the original swaps. Following the settlement, the Company
entered into interest rate swaps with matching notional amounts with expiration in June 2026.
As of September 30, 2023, the Company effectively had (i) a $450 million interest rate swap transaction
that swaps a one-month variable SOFR contract for a fixed annual rate of 4.043%, (ii) a $400 million interest
rate swap transaction that swaps a one-month variable SOFR contract for a fixed annual rate of 4.451%,
(iii) an $884 million interest rate swap transaction that swaps a one-month variable SOFR contract for a fixed
annual rate of 4.451%, (iv) a $473 million interest rate swap transaction that swaps a one-month variable
SOFR contract for a fixed annual rate of 3.869%, and (v) a $500 million interest rate swap transaction that
swaps a one-month variable SOFR contract for a fixed annual rate of 3.602%%. The Company’s interest rate
swap transactions all expire in June 2026. See Note 12. Subsequent Events.
Balances of our derivative instruments on a gross basis are as follows:
Derivative Instruments
Hedge Designation
Balance Sheet Location
2023
2022
Cross-currency swaps . . . . . . . . . . . . . . . . . Designated
Other assets
Cross-currency swaps . . . . . . . . . . . . . . . . . Designated
Other current liabilities
Cross-currency swaps . . . . . . . . . . . . . . . . . Designated
Other long-term liabilities
Interest rate swaps . . . . . . . . . . . . . . . . . . . Designated
Other assets
$ — $147
—
66
19
36
Interest rate swaps . . . . . . . . . . . . . . . . . . . Not designated Other assets
Interest rate swaps . . . . . . . . . . . . . . . . . . . Designated
8
Other long-term liabilities —
104
Interest rate swaps . . . . . . . . . . . . . . . . . . . Not designated Other long-term liabilities
32
—
11
—
3
117
The effect of the Company’s derivative instruments on the Consolidated Statements of Income is as
follows:
Derivative instruments
Statements of
Income Location
2023
2022
2021
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cross-currency swaps
Interest rate swaps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense
Interest expense
$(41) $(21) $ (8)
(59)
69
40
The amortization related to unrealized losses in Accumulated other comprehensive loss is expected to
be $36 million in the next 12 months. The Company’s financial instruments consist primarily of cash and
cash equivalents, long-term debt, interest rate swap agreements, cross-currency swap agreements and capital
lease obligations. The book value of our long-term indebtedness exceeded fair value by $381 million as of
fiscal 2023 and by $561 million as of fiscal 2022. The Company’s long-term debt fair values were determined
using Level 2 inputs as other significant observable inputs were not available.
Non-recurring Fair Value Measurements
The Company has certain assets that are measured at fair value on a non-recurring basis when
impairment indicators are present or when the Company completes an acquisition. The Company adjusts
certain long-lived assets to fair value only when the carrying values exceed the fair values. The categorization
of the framework used to value the assets is considered Level 3, due to the subjective nature of the
unobservable inputs used to determine the fair value.
Included in the following tables are the major categories of assets and their current carrying values,
along with the impairment loss recognized on the fair value measurement for the fiscal years then ended:
Level 1
Level 2
Level 3
Total
Impairment
2023
Indefinite lived trademarks . . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Definite lived intangible assets . . . . . . . . . . . . . . . . . . .
Property, plant and equipment . . . . . . . . . . . . . . . . . . .
$ — $ — $
—
—
—
—
—
—
248
4,981
1,455
4,576
$
248
4,981
1,455
4,576
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ — $ — $11,260
$11,260
$—
—
—
8
$ 8
Level 1
Level 2
Level 3
Total
Impairment
2022
Indefinite lived trademarks . . . . . . . . . . . . . . . . . . . . .
Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Definite lived intangible assets . . . . . . . . . . . . . . . . . . .
Property, plant and equipment . . . . . . . . . . . . . . . . . . .
$ — $ — $
—
—
—
—
—
—
247
4,832
1,606
4,342
$
247
4,832
1,606
4,342
$ —
—
—
—
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ — $ — $11,027
$11,027
$ —
5. Commitments, Leases and Contingencies
The Company has various purchase commitments for raw materials, supplies and property and
equipment incidental to the ordinary conduct of business.
Collective Bargaining Agreements
At the end of fiscal 2023, we employed approximately 44,000 employees, and approximately 20% of
those employees were covered by collective bargaining agreements. The majority of these agreements are
due for renegotiation annually.
33
Leases
Supplemental lease information is as follows:
Leases
Operating leases:
Classification
2023
2022
Operating lease right-of-use assets
Current operating lease liabilities . . . . . . . . . . . . Other current liabilities
. . . . . . . . . Operating lease liability
Noncurrent operating lease liabilities
. . . . . . . . . . . Right-of-use asset
Finance leases:
Finance lease right-of-use assets . . . . . . . . . . . . . Property, plant, and equipment, net
Current finance lease liabilities . . . . . . . . . . . . . . Current portion of long-term debt
Noncurrent finance lease liabilities . . . . . . . . . . . Long-term debt, less current portion
Cash Flow Classification
Lease Type
Operating leases . . . . . . . . . . Operating cash flows Lease cost
Finance leases . . . . . . . . . . . Operating cash flows
Finance leases . . . . . . . . . . . Financing cash flows —
Finance leases . . . . . . . . . . . —
Interest expense
Lease Expense Category
Amortization of right-of-use assets
$625
116
525
$ 32
9
19
2023
$141
1
5
9
$521
108
429
$ 38
9
24
2022
$132
2
19
9
Weighted-average remaining lease term – operating leases . . . . . . . . . . . . . . .
Weighted-average remaining lease term – finance leases . . . . . . . . . . . . . . . .
Weighted-average discount rate – operating leases . . . . . . . . . . . . . . . . . . . .
Weighted-average discount rate – finance leases . . . . . . . . . . . . . . . . . . . . . .
2023
9 years
2 years
5.0%
4.5%
2022
7 years
3 years
4.5%
4.5%
Right-of-use assets obtained in exchange for new operating lease liabilities were $109 million for fiscal
2023.
Litigation
The Company is party to various legal proceedings involving routine claims which are incidental to its
business. Although the Company’s legal and financial liability with respect to such proceedings cannot be
estimated with certainty, the Company believes that any ultimate liability would not be material to its financial
position, results of operations or cash flows.
6. Income Taxes
The Company is being taxed at the U.S. corporate level as a C-Corporation and has provided U.S.
Federal, State and foreign income taxes. Significant components of income tax expense for the fiscal years
ended are as follows:
Current
U.S.
Federal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
State . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total current
Deferred:
U.S.
2023
2022
2021
$ 118
25
107
250
$ 87
20
109
216
$ 56
14
175
245
Federal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
State . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expense for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(26)
(26)
(65)
(117)
$ 133
4
(7)
(45)
(48)
$168
17
(6)
(84)
(73)
$172
34
U.S. income from continuing operations before income taxes was $375 million, $449 million, and
$276 million for fiscal 2023, 2022, and 2021, respectively. Non-U.S. income from continuing operations
before income taxes was $367 million, $485 million, and $629 million for fiscal 2023, 2022, and 2021,
respectively. The Company paid cash taxes of $240 million, $186 million, and $200 million in fiscal 2023,
2022, and 2021, respectively.
The reconciliation between U.S. Federal income taxes at the statutory rate and the Company’s benefit
for income taxes on continuing operations for fiscal years ended are as follows:
U.S. Federal income tax expense at the statutory rate . . . . . . . . . . . . . . . .
Adjustments to reconcile to the income tax provision:
U.S. state income tax expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Federal and state credits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Share-based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax law changes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Withholding taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Changes in foreign valuation allowance . . . . . . . . . . . . . . . . . . . . . . . .
Foreign income taxed in the U.S.
. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rate differences between U.S. and foreign . . . . . . . . . . . . . . . . . . . . . .
Sale of subsidiary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Permanent foreign currency differences . . . . . . . . . . . . . . . . . . . . . . . .
Uncertain tax positions, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expense for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2023
$156
2022
$196
2021
$190
5
11
20
(18)
(10)
(15)
—
(8)
(3)
— (17)
11
10
13
6
7
(14)
(5)
17
12
8
(22)
(8)
(8)
—
—
16
—
— (30)
(20)
(5)
(19)
(2)
(6)
5
$133
$172
$168
Deferred income taxes result from temporary differences between the amount of assets and liabilities
recognized for financial reporting and tax purposes. The components of the net deferred income tax liability
as of fiscal years ended are as follows:
Deferred tax assets:
Accrued liabilities and reserves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net operating loss carryforward . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense carryforward . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Lease liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Research and development credit carryforward . . . . . . . . . . . . . . . . . . . . .
Federal and state tax credits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Capitalization research and development expenditures . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total deferred tax assets, net of valuation allowance . . . . . . . . . . . . . . . .
Total deferred tax assets
Deferred tax liabilities:
2023
2022
$
72
13
274
121
159
13
11
39
38
740
(114)
626
$
75
11
235
107
134
13
9
—
48
632
(104)
528
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Property, plant and equipment
Intangible assets
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Leased asset
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total deferred tax liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net deferred tax liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
471
450
437
471
22
94
155
131
22
24
1,107
1,170
$ (481) $ (642)
35
The Company had $92 million of net deferred tax assets recorded in Other assets, and $573 million of
net deferred tax liabilities recorded in Deferred income taxes on the Consolidated Balance Sheets.
As of September 30, 2023, the Company has recorded deferred tax assets related to federal, state, and
foreign net operating losses, interest expense, and tax credits. These attributes are spread across multiple
jurisdictions and generally have expiration periods beginning in 2021 while a portion remains available
indefinitely. Each attribute has been assessed for realization and a valuation allowance is recorded against the
deferred tax assets to bring the net amount recorded to the amount more likely than not to be realized.
The valuation allowance against deferred tax assets was $114 million and $104 million as of the fiscal years
ended 2023 and 2022, respectively, related to the foreign and U.S. federal and state operations.
The Company is permanently reinvested except to the extent the foreign earnings are previously taxed
or to the extent that we have sufficient basis in our non-U.S. subsidiaries to repatriate earnings on an income
tax free basis.
Uncertain Tax Positions
The following table summarizes the activity related to our gross unrecognized tax benefits for fiscal years
ended:
Beginning unrecognized tax benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross increases – tax positions in prior periods . . . . . . . . . . . . . . . . . . . . . . . .
Gross decreases – tax positions in prior periods . . . . . . . . . . . . . . . . . . . . . . .
Gross increases – current period tax positions
. . . . . . . . . . . . . . . . . . . . . . . .
Settlements
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Lapse of statute of limitations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Ending unrecognized tax benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2023
2022
$121
17
(11)
12
—
(32)
$107
$159
2
(19)
13
(9)
(25)
$121
As of fiscal year end 2023, the amount of unrecognized tax benefit that, if recognized, would affect
our effective tax rate was $105 million and we had $33 million accrued for payment of interest and penalties
related to our uncertain tax positions. Our penalties and interest related to uncertain tax positions are
included in income tax expense.
As a result of global operations, we file income tax returns in the U.S. federal, various state and local,
and foreign jurisdictions and are routinely subject to examination by taxing authorities throughout the
world. Excluding potential adjustments to net operating losses, the U.S. federal and state income tax returns
are no longer subject to income tax assessments for years before 2019. With few exceptions, the major
foreign jurisdictions are no longer subject to income tax assessments for year before 2016.
7. Retirement Plans
The Company sponsors defined contribution retirement plans covering substantially all employees.
Contributions are based upon a fixed dollar amount for employees who participate and percentages of
employee contributions at specified thresholds. Contribution expense for these plans was $40 million,
$42 million, and $45 million for fiscal 2023, 2022, and 2021, respectively.
The majority of the North American and UK defined benefit pension plans, which cover certain
manufacturing facilities, are closed to future entrants. The assets of all the plans are held in a separate
trustee administered fund to meet long-term liabilities for past and present employees. The majority,
$63 million, of Mainland Europe’s total underfunded status relates to non-contributory pension plans within
our German operations. There is no external funding for these plans although they are secured by insolvency
insurance required under German law. In general, the plans provide a fixed retirement benefit not related
to salaries and are closed to new entrants.
The net amount of liability recognized is included in Employee Benefit Obligations on the Consolidated
Balance Sheets. The Company uses fiscal year end as a measurement date for the retirement plans.
36
2023
2022
Change in Projected
Benefit Obligations (PBO)
Beginning of period . . . . . . . . . .
Service cost . . . . . . . . . . . . . . . .
Interest cost . . . . . . . . . . . . . . . .
Currency . . . . . . . . . . . . . . . . . .
Actuarial loss (gain) . . . . . . . . . .
Benefit settlements . . . . . . . . . . .
Benefits paid . . . . . . . . . . . . . . .
North
America
$252
—
12
—
(10)
(20)
(16)
UK
$480
—
26
54
(26)
—
(29)
End of period . . . . . . . . . . . . . .
$218
$505
Mainland
Europe
$124
4
5
11
(5)
(1)
(7)
$131
Total
$856
4
43
65
(41)
(21)
(52)
$854
North
America
$338
—
8
(1)
(77)
—
(16)
UK
$ 888
1
17
(152)
(244)
—
(30)
$252
$ 480
Mainland
Europe
$196
5
2
(30)
(37)
(5)
(7)
$124
Change in Fair
Value of Plan Assets
Beginning of period . . . . . . . . . .
Currency . . . . . . . . . . . . . . . . .
Return on assets . . . . . . . . . . . .
Contributions . . . . . . . . . . . . . .
Benefit settlements
. . . . . . . . . .
Benefits paid . . . . . . . . . . . . . .
End of period . . . . . . . . . . . . . .
Underfunded status . . . . . . . . . .
2023
2022
North
America
$228
—
29
—
(20)
(16)
$221
$ 3
UK
$446
51
(73)
19
—
(29)
$414
$ (91)
Mainland
Europe
$ 40
2
1
8
(1)
(7)
$ 43
$(88)
Total
$ 714
53
(43)
27
(21)
(52)
$ 678
North
America
$286
(1)
(41)
—
—
(16)
UK
$ 828
(146)
(225)
19
—
(30)
$228
$ 446
$(176)
$ (24)
$ (34)
Mainland
Europe
$ 53
(7)
(2)
8
(5)
(7)
$ 40
$(84)
Total
$1,422
6
27
(183)
(358)
(5)
(53)
$ 856
Total
$1,167
(154)
(268)
27
(5)
(53)
$ 714
$ (142)
At the end of fiscal 2023, the Company had $112 million of net unrealized losses recorded in
Accumulated other comprehensive loss on the Consolidated Balance Sheets. The Company expects less than
$1 million to be realized in fiscal 2024.
The following table presents significant weighted-average assumptions used to determine benefit
obligation and benefit cost for the fiscal years ended:
(Percentages)
Weighted-average assumptions:
Discount rate for benefit obligation . . . . . . . . . . . . . . . . . . . . . . . . . .
Discount rate for net benefit cost
. . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected return on plan assets for net benefit costs . . . . . . . . . . . . . . .
(Percentages)
Weighted-average assumptions:
Discount rate for benefit obligation . . . . . . . . . . . . . . . . . . . . . . . . . .
Discount rate for net benefit cost
. . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected return on plan assets for net benefit costs . . . . . . . . . . . . . . .
North
America
5.6
5.1
6.1
North
America
5.1
2.5
6.1
2023
UK
5.5
5.2
5.7
2022
UK
5.2
2.1
4.2
Mainland
Europe
4.1
3.7
2.6
Mainland
Europe
3.6
1.0
2.1
In evaluating the expected return on plan assets, Berry considered its historical assumptions compared
with actual results, an analysis of current market conditions, asset allocations, and the views of advisors.
The return on plan assets is derived from target allocations and historical yield by asset type. A one quarter
of a percentage point reduction of expected return on pension assets, mortality rate or discount rate
applied to the pension liability would result in an immaterial change to the Company’s pension expense.
37
In accordance with the guidance from the FASB for employers’ disclosure about postretirement benefit
plan assets the table below discloses fair values of each pension plan asset category and level within the fair
value hierarchy in which it falls. There were no material changes or transfers between level 3 assets and
the other levels.
Fiscal 2023 Asset Category
Level 1
Level 2
Level 3
Total
Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. large cap comingled equity funds . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. mid cap equity mutual funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. small cap equity & Corporate bond mutual funds
. . . . . . . . . . . . . .
International equity mutual funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Real estate equity investment funds . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Corporate bonds
International fixed income funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
International insurance policies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 23
80
33
2
6
—
—
6
—
$150
$ — $ — $ 23
—
80
—
33
—
2
—
39
105
126
167
70
— 164
44
44
—
—
—
33
21
97
158
—
$309
$219
$678
Fiscal 2022 Asset Category
Level 1
Level 2
Level 3
Total
Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. large cap comingled equity funds . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. mid cap equity mutual funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.S. small cap equity & Corporate bond mutual funds
. . . . . . . . . . . . . .
International equity mutual funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Real estate equity investment funds . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Corporate bonds
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
International fixed income funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
International insurance policies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 14
69
35
4
9
4
—
5
—
$140
$ — $ — $ 14
—
69
—
35
—
4
— 108
124
94
56
184
— 135
41
41
—
—
—
99
26
128
130
—
$383
$191
$714
The following benefit payments, which reflect expected future service, as appropriate, are expected to
be paid for the fiscal year end:
2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$18
$ 29
$ 9
North
America
UK
Mainland
Europe
Total
$ 56
53
53
56
58
30
31
32
33
7
6
7
8
179
49
308
2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2027 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2028 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2029 – 2033 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
16
16
17
17
80
38
Net pension expense is recorded in Cost of goods sold and included the following components as of
fiscal years ended:
Service cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization of net actuarial loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected return on plan assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net periodic benefit expense (income) . . . . . . . . . . . . . . . . . . . . . . . . . . .
2023
2022
2021
$ 4
43
1
(46)
$ 2
$ 6
27
3
(51)
$ 5
24
9
(51)
$(15) $(13)
Our defined benefit pension plan asset allocations as of fiscal years ended are as follows:
Asset Category
Equity securities and equity-like instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Debt securities and debt-like . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
International insurance policies
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2023
2022
41% 47%
49
7
3
45
6
2
Total
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
100% 100%
The Company’s retirement plan assets are invested with the objective of providing the plans the ability
to fund current and future benefit payment requirements while minimizing annual Company contributions.
The retirement plans held $31 million of the Company’s stock at the end of fiscal 2023. The Company re-
addresses the allocation of its investments on a regular basis.
8. Restructuring and Transaction Activities
In the current fiscal year, the Company initiated cost savings initiatives including plant rationalization
in all four segments as part of the 2023 restructuring plan. The Company expects total cash and non-cash
expense to be approximately $200 million, with the operations savings intended to counter general economic
softness. The initiatives are expected to be fully implemented by the end of fiscal 2025. During fiscal 2021
and 2022, the Company did not shut down any facilities with significant net sales.
The table below includes the significant components of our restructuring and transaction activities
recognized for the fiscal years ended, by reporting segment:
Consumer Packaging International . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consumer Packaging North America . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Engineered Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Health, Hygiene & Specialties
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2023
2022
2021
$ 50
23
7
22
$10
$56
5 —
2
6
(4)
(1)
Consolidated . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$102
$23
$51
Transaction activities consist of acquisition, divestiture and other business optimization related costs.
The table below sets forth the activity with respect to the restructuring charges and the impact on our accrued
restructuring reserves:
39
Restructuring(a)
Employee Severance
and Benefits
Facility
Exit Costs
Non-cash
Impairment Charges
Transaction
Activities
Balance as of fiscal 2021 . . . . . . . . . .
Charges . . . . . . . . . . . . . . . . . . . . . .
Cash . . . . . . . . . . . . . . . . . . . . . . . .
Balance as of fiscal 2022 . . . . . . . . . .
Charges . . . . . . . . . . . . . . . . . . . . . .
Non-cash items . . . . . . . . . . . . . . . .
Cash . . . . . . . . . . . . . . . . . . . . . . . .
Balance as of fiscal 2023 . . . . . . . . . .
$ 6
7
(11)
$ 2
39
—
(31)
$ 10
$ 5
9
(11)
$ 3
23
—
(25)
$ 1
$—
—
—
$—
8
(8)
—
$—
$ —
7
(7)
$ —
32
—
(32)
$ —
Total
$ 11
23
(29)
$ 5
102
(8)
(88)
$ 11
(a) Since 2021, cumulative costs attributed to restructuring programs total $105 million.
9. Stockholders’ Equity
Share Repurchases
During fiscal 2023, the Company repurchased approximately 9.8 million shares for $601 million, at an
average price of $61.00. During fiscal 2022, the Company repurchased approximately 12.2 million shares for
$709 million, at an average price of $58.30. No shares were repurchased during fiscal 2021.
All share repurchases were immediately retired. Common stock was reduced by the number of shares
retired at $0.01 par value per share. The Company allocates the excess purchase price over par value between
additional paid-in capital and retained earnings. As of fiscal 2023, authorized repurchases of $442 million
remain available to the Company.
Equity Incentive Plans
The Company has shareholder-approved stock plans under which options and restricted stock units
have been granted to employees at the market value of the Company’s stock on the date of grant. In fiscal
2021, the Company amended the 2015 Berry Global Group, Inc. Long-Term Incentive Plan to authorize the
issuance of 20.8 million shares, an increase of 8.3 million shares from the previous authorization. The
intrinsic value of options exercised in fiscal 2023 was $27 million.
Information related to the equity incentive plans as of the fiscal years ended are as follows:
2023
2022
Number of Shares
(in thousands)
Weighted Average
Exercise Price
Number of Shares
(in thousands)
Weighted Average
Exercise Price
Options outstanding, beginning of
period . . . . . . . . . . . . . . . . . . . . .
Options granted . . . . . . . . . . . . . . . .
Options exercised . . . . . . . . . . . . . . .
Options forfeited or cancelled . . . . . . .
Options outstanding, end of period . .
11,656
1,343
(1,041)
(122)
11,836
$47.33
56.93
35.85
53.96
$49.36
11,302
1,192
(752)
(86)
$44.54
66.47
35.31
51.72
11,656
$47.33
Option price range at end of period . .
$21.00 – 66.47
Options exercisable at end of period . .
Weighted average fair value of options
granted during period . . . . . . . . . .
$
7,349
17.53
$16.00 – 66.47
6,718
$
20.73
Generally, options vest annually in equal installments commencing one year from the date of grant and
have a vesting term of either four or five years, depending on the grant date, and an expiration term of
40
10 years from the date of grant. The fair value for options granted has been estimated at the date of grant
using a Black-Scholes model using the following key assumptions:
Risk-free interest rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dividend yield . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Volatility factor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2023
2022
2021
3.8% 1.3% 0.5%
1.7% 0.0% 0.0%
31.0% 29.7% 30.4%
The following table summarizes information about the options outstanding as of fiscal 2023:
Intrinsic Value of Outstanding
(in millions)
Weighted
Remaining
Contractual Life
Number
Exercisable
(in thousands)
Intrinsic Value
of Exercisable
(in millions)
Unrecognized
Compensation
(in millions)
$154 . . . . . . . . . . . . . . . . . . . . . . .
5.7 years
7,349
$117
$43
Weighted
Recognition
Period
1.4 years
The Company’s issued restricted stock units generally vest in equal installments over four years.
Compensation cost is recorded based upon the fair value of the shares at the grant date.
2023
2022
Number of Shares
(in thousands)
Weighted Average
Grant Price
Number of Shares
(in thousands)
Weighted Average
Grant Price
Awards outstanding, beginning of
period . . . . . . . . . . . . . . . . . . . . .
Awards granted . . . . . . . . . . . . . . . .
Awards vested . . . . . . . . . . . . . . . . .
Awards forfeited or cancelled . . . . . . .
Awards outstanding, end of period . . .
354
434
(105)
(23)
660
$61.99
56.93
61.46
59.75
$58.82
196
232
(64)
(10)
354
$54.22
66.47
54.70
60.30
$61.99
The Company had equity incentive shares available for grant of 5.0 million and 7.1 million as of
September 30, 2023 and October 1, 2022, respectively.
10. Segment and Geographic Data
Berry’s operations are organized into four reporting segments: Consumer Packaging International,
Consumer Packaging North America, Engineered Materials, and Health, Hygiene & Specialties. The
structure is designed to align us with our customers, provide improved service, and drive future growth in a
cost efficient manner.
Selected information by reportable segment is presented in the following tables:
2023
2022
2021
Net sales
Consumer Packaging International . . . . . . . . . . . . . . . . . . .
$ 4,031
$ 4,293
$ 4,242
Consumer Packaging North America . . . . . . . . . . . . . . . . .
Engineered Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Health, Hygiene & Specialties . . . . . . . . . . . . . . . . . . . . . .
3,122
2,884
2,627
3,548
3,488
3,166
3,141
3,309
3,158
Total
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$12,664
$14,495
$13,850
Operating income
Consumer Packaging International . . . . . . . . . . . . . . . . . . .
$
Consumer Packaging North America . . . . . . . . . . . . . . . . .
Engineered Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Health, Hygiene & Specialties . . . . . . . . . . . . . . . . . . . . . .
$
273
346
333
127
$
346
338
328
230
317
276
301
398
Total
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 1,079
$ 1,242
$ 1,292
41
2023
2022
2021
Depreciation and amortization
Consumer Packaging International . . . . . . . . . . . . . . . . . . .
Consumer Packaging North America . . . . . . . . . . . . . . . . .
Engineered Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Health, Hygiene & Specialties . . . . . . . . . . . . . . . . . . . . . .
Total
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$
$
310
217
114
177
818
$
$
317
214
112
176
819
$
$
341
224
112
177
854
2023
2022
Total assets:
Consumer Packaging International
. . . . . . . . . . . . . . . . . . . . . . . . . .
Consumer Packaging North America . . . . . . . . . . . . . . . . . . . . . . . .
Engineered Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Health, Hygiene & Specialties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 6,217
4,312
2,476
3,582
$ 6,993
3,992
2,236
3,735
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$16,587
$16,956
Selected information by geographical region is presented in the following tables:
Net sales:
United States and Canada . . . . . . . . . . . . . . . . . . . . . . . . .
Europe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rest of world . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 6,893
4,559
1,212
$12,664
$ 7,907
5,065
1,523
$14,495
$ 7,351
4,898
1,601
$13,850
2023
2022
2021
Long-lived assets:
United States and Canada . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Europe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rest of world . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 6,893
3,800
1,361
$ 6,826
3,616
1,350
Total long-lived assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$12,054
$11,792
2023
2022
Selected information by product line is presented in the following tables:
(in percentages)
Net sales:
2023
2022
2021
Packaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-packaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consumer Packaging International . . . . . . . . . . . . . . . . . . . . . . . . .
Rigid Open Top . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rigid Closed Top . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consumer Packaging North America . . . . . . . . . . . . . . . . . . . . . . .
Core Films
Retail & Industrial
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Engineered Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hygiene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Specialties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Health, Hygiene & Specialties . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
42
19
43
76% 76% 81%
24
24
100% 100% 100%
66% 62% 57%
34
38
100% 100% 100%
60% 59% 63%
40
41
100% 100% 100%
14% 14% 18%
48
51
38
35
100% 100% 100%
47
35
37
11. Net Income per Share
Basic net income or earnings per share (“EPS”) is calculated by dividing the net income attributable to
common stockholders by the weighted-average number of common shares outstanding during the period,
without consideration for common stock equivalents. Diluted EPS includes the effects of options and restricted
stock units, if dilutive.
The following tables provide a reconciliation of the numerator and denominator of the basic and
diluted EPS calculations:
(in millions, except per share amounts)
2023
2022
2021
Numerator
Consolidated net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Denominator
$ 609
$ 766
$ 733
Weighted average common shares outstanding – basic . . . . . . . . . . .
Dilutive shares . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
120.1
2.9
130.6
2.2
134.6
3.7
Weighted average common and common equivalent shares
outstanding – diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
123.0
132.8
138.3
Per common share earnings
Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$ 5.07
$ 4.95
$ 5.87
$ 5.77
$ 5.45
$ 5.30
1 million shares were excluded from the fiscal 2023 and 2022 diluted EPS calculation, respectively, as
their effect would be anti-dilutive. No shares were excluded from the fiscal 2021 calculation.
12. Subsequent Events
In October 2023, the Company extended the maturity date of $1,550 million of the Term Loans and
$950 million of outstanding interest rate swaps to July 2029.
In November 2023, the Company’s Board of Directors authorized a quarterly cash dividend of $0.275
per share. The first fiscal quarter payment will be paid on December 15, 2023 to shareholders of record as
of December 1, 2023.
43
Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
None.
Item 9A. CONTROLS AND PROCEDURES
Evaluation of disclosure controls and procedures
We maintain “disclosure controls and procedures,” as such term is defined in Rule 13a-15(e) under the
Exchange Act, that are designed to ensure that information required to be disclosed by us in reports that we
file or submit under the Exchange Act is recorded, processed, summarized and reported within the time
periods specified in SEC rules and forms, and that such information is accumulated and communicated to
our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow
timely decisions regarding required disclosure.
In connection with the preparation of this Form 10-K, management evaluated the effectiveness of the
design and operation of our disclosure controls and procedures as of September 30, 2023. Based on this
evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the Company’s
disclosure controls and procedures were effective as of September 30, 2023.
Management’s Report on Internal Controls over Financial Reporting
Management is responsible for establishing and maintaining adequate internal control over financial
reporting. Under the supervision and with the participation of our management, the Company conducted
an evaluation of the effectiveness of our internal control over financial reporting using the criteria set forth by
the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Based on
this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the Company’s
internal controls over financial reporting were effective as of September 30, 2023.
The effectiveness of our internal control over financial reporting as of September 30, 2023, has been
audited by the Company’s independent registered public accounting firm, as stated in their report, which is
included herein.
Changes in Internal Controls over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the quarter
ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our
internal control over financial reporting.
Item 9B. OTHER INFORMATION
Rule 10b5-1 Trading Plans
No officers or directors, as defined in Rule 16a-1(f), adopted, modified and/or terminated a “Rule 10b5-1
trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408,
during the fourth quarter of fiscal 2023.
Item 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
None.
44
PART III
Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Except as set forth below, the information required by this Item is incorporated herein by reference to
our definitive Proxy Statement to be filed in connection with the 2024 Annual Meeting of Stockholders.
We have a Global Code of Business Ethics that applies to all directors and employees, including our
Chief Executive Officer and senior financial officers. We also have adopted a Supplemental Code of Ethics,
which is in addition to the standards set by our Global Code of Business Ethics, in order to establish a
higher level of expectation for the most senior leaders of the Company. Our Global Code of Business Ethics
and Supplemental Code of Ethics can be obtained, free of charge, by contacting our corporate headquarters
or can be obtained from the Corporate Governance section of the Investors page on the Company’s
internet site. In the event that we make changes in, or provide waivers from, the provision of the Code of
Business Ethics that the SEC requires us to disclose, we will disclose these events in the corporate governance
section of our website within four business days following the date of such amendment or waiver.
Item 11. EXECUTIVE COMPENSATION
The information required by this Item is incorporated herein by reference to our definitive Proxy
Statement to be filed in connection with the 2024 Annual Meeting of Stockholders.
Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
AND RELATED STOCKHOLDER MATTERS
The information required by this Item, is incorporated herein by reference to our definitive Proxy
Statement to be filed in connection with the 2024 Annual Meeting of Stockholders.
Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR
INDEPENDENCE
The information required by this Item is incorporated herein by reference to our definitive Proxy
Statement to be filed in connection with the 2024 Annual Meeting of Stockholders.
Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
The information required by this Item is incorporated herein by reference to our definitive Proxy
Statement to be filed in connection with the 2024 Annual Meeting of Stockholders.
45
PART IV
Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
1. Financial Statements
The financial statements listed under Item 8 are filed as part of this report.
2. Financial Statement Schedules
Schedules have been omitted because they are either not applicable or the required information
has been disclosed in the financial statements or notes thereto.
3. Exhibits
The exhibits listed on the Exhibit Index immediately following the signature page of this annual
report are filed as part of this report.
Item 16. FORM 10-K SUMMARY
None.
Exhibit No
Description of Exhibit
2.1
2.2
3.1*
3.2
4.1
4.2
4.2A
4.3
Rule 2.7 Announcement, dated as of March 8, 2019 (incorporated by reference to Exhibit 2.1
to the Company’s Current Report on Form 8-K filed on March 14, 2019).
Co-Operation Agreement, dated as of March 8, 2019, by and among Berry Global Group,
Inc., Berry Global International Holdings Limited and RPC Group Plc (incorporated by
reference to Exhibit 2.2 to the Company’s Current Report on Form 8-K filed on March 14,
2019).
Amended and Restated Certificate of Incorporation of Berry Global Group, Inc., as
amended through February 24, 2021.
Amended and Restated Bylaws of Berry Global Group, Inc., as amended and restated
effective as of February 24, 2021 (incorporated by reference to Exhibit 3.2 to the Company’s
Current Report on Form 8-K filed on February 25, 2021).
Form of common stock certificate of Berry Plastics Group, Inc. (incorporated by reference to
Exhibit 4.27 of Amendment No. 5 to the Company’s Registration Statement on Form S-1
filed on September 19, 2012).
Indenture, by and between Berry Global Escrow Corporation and U.S. Bank Trust Company
National Association (as successor to U.S. Bank National Association), as Trustee and
Collateral Agent, relating to the 4.875% First Priority Senior Secured Notes due 2026, dated
June 5, 2019 (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on
Form 8-K filed on June 6, 2019).
Supplemental Indenture, among Berry Global Group, Inc., Berry Global, Inc., Berry Global
Escrow Corporation, each of the parties identified as a Subsidiary Guarantor thereon, and
U.S. Bank Trust Company National Association (as successor to U.S. Bank National
Association), as Trustee, relating to the 4.875% First Priority Senior Secured Notes due 2026,
dated July 1, 2019 (incorporated by reference to Exhibit 4.1 to the Company’s Current Report
on Form 8-K filed on July 2, 2019).
Indenture, by and between Berry Global Escrow Corporation and U.S. Bank Trust Company
National Association (as successor to U.S. Bank National Association), as Trustee and
Collateral Agent, relating to the 5.625% Second Priority Senior Secured Notes due 2027,
dated June 5, 2019 (incorporated by reference to Exhibit 4.2 to the Company’s Current
Report on Form 8-K filed on June 6, 2019).
46
Exhibit No
4.3A
4.4
4.5
4.5A
4.6
4.7
4.8
4.9
4.10
Description of Exhibit
Supplemental Indenture, among Berry Global Group, Inc., Berry Global, Inc., Berry Global
Escrow Corporation, each of the parties identified as a Subsidiary Guarantor thereon, and
U.S. Bank Trust Company National Association (as successor to U.S. Bank National
Association), as Trustee, relating to the 5.625% Second Priority Senior Secured Notes due
2027, dated July 1, 2019 (incorporated by reference to Exhibit 4.2 to the Company’s Current
Report on Form 8-K filed on July 2, 2019).
Indenture, among Berry Global, Inc., certain guarantors party thereto, U.S. Bank Trust
Company National Association (as successor to U.S. Bank National Association), as Trustee
and Collateral Agent, and Elavon Financial Services DAC, as Paying Agent, Transfer Agent
and Registrar, relating to the 1.00% First Priority Senior Secured Notes due 2025 and 1.50%
First Priority Senior Secured Notes due 2027, dated January 2, 2020 (incorporated by
reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on January 2,
2020).
Indenture among Berry Global, Inc., certain guarantors party thereto, U.S. Bank Trust
Company National Association (as successor to U.S. Bank National Association), as Trustee
and Collateral Agent, relating to the 1.57% First Priority Senior Secured Notes due 2026,
dated December 22, 2020 (incorporated by reference to Exhibit 4.1 to the Company’s Current
Report on Form 8-K filed on December 23, 2020).
First Supplemental Indenture, among Berry Global, Inc., certain guarantors party thereto,
U.S. Bank Trust Company National Association (as successor to U.S. Bank National
Association), as Trustee and Collateral Agent, relating to the 1.57% First Priority Senior
Secured Notes due 2026, dated March 4, 2021 (incorporated by reference to Exhibit 4.1 to the
Company’s Current Report on Form 8-K filed on March 4, 2021).
Indenture among Berry Global, Inc., certain guarantors party thereto, U.S. Bank Trust
Company National Association (as successor to U.S. Bank National Association), as Trustee
and Collateral Agent, relating to the 0.95% First Priority Senior Secured Notes due 2024,
dated January 15, 2021 (incorporated by reference to Exhibit 4.1 to the Company’s Current
Report on Form 8-K filed on January 15, 2021).
Indenture, among Berry Global, Inc., certain guarantors party thereto, U.S. Bank Trust
Company National Association (as successor to U.S. Bank National Association), as Trustee
and Collateral Agent, relating to the 1.65% First Priority Senior Secured Notes due 2027,
dated June 14, 2021 (incorporated by reference to Exhibit 4.1 to the Company’s Current
Report on Form 8-K filed on June 14, 2021).
Indenture, among Berry Global, Inc., certain guarantors party thereto, U.S. Bank Trust
Company, National Association, as Trustee and Collateral Agent, relating to the 5.50% First
Priority Senior Secured Notes due 2028, dated March 30, 2023 (incorporated by reference to
Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on March 30, 2023).
Registration Rights Agreement, by and between Berry Global, Inc., Berry Global Group,
Inc., each subsidiary of Berry Global, Inc. identified therein, and Citigroup Global Markets
Inc. and J.P. Morgan Securities LLC, on behalf of themselves and as representatives of the
initial purchasers, relating to the 1.57% First Priority Senior Secured Notes due 2026
(incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K
filed on December 23, 2020).
Registration Rights Agreement, by and between Berry Global, Inc., Berry Global Group,
Inc., each subsidiary of Berry Global, Inc. identified therein, and Citigroup Global Markets
Inc. and J.P. Morgan Securities LLC, on behalf of themselves and as representatives of the
initial purchasers, relating to the 0.95% First Priority Senior Secured Notes due 2024
(incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K
filed on January 15, 2021).
47
Exhibit No
4.11
4.12
4.13
4.14
10.1
10.2
10.3
10.4
Description of Exhibit
Registration Rights Agreement, dated March 4, 2021, by and between Berry Global, Inc.,
Berry Global Group, Inc., each subsidiary of Berry Global, Inc. identified therein, and
Citigroup Global Markets Inc. Goldman Sachs & Co. LLC and Wells Fargo Securities, LLC,
on behalf of themselves and as representatives of the initial purchasers, relating to the 1.57%
First Priority Senior Secured Notes due 2026 (incorporated by reference to Exhibit 4.2 to the
Company’s Current Report on Form 8-K filed on March 5, 2021).
Registration Rights Agreement, by and between Berry Global, Inc., Berry Global Group,
Inc., each subsidiary of Berry Global, Inc. identified therein, and J.P. Morgan Securities
LLC, Citigroup Global Markets Inc. and Goldman Sachs & Co. LLC, on behalf of
themselves and as representatives of the initial purchasers, relating to the 1.65% First Priority
Senior Secured Notes due 2027 (incorporated by reference to Exhibit 4.2 to the Company’s
Current Report on Form 8-K filed on June 14, 2021).
Registration Rights Agreement, by and between Berry Global, Inc., Berry Global Group,
Inc., each subsidiary of Berry Global, Inc. identified therein, and Citigroup Global Markets
Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, on behalf of themselves
and as representatives of the initial purchasers, relating to the 5.50% First Priority Senior
Secured Notes due 2028 (incorporated by reference to Exhibit 4.2 to the Company’s Current
Report on Form 8-K filed on March 30, 2023).
Description of Securities (incorporated by reference to Exhibit 4.9 to the Company’s Annual
Report on Form 10-K filed on November 11, 2019).
$1,000,000,000 Fourth Amended and Restated Revolving Credit Agreement, dated as of
June 22, 2023, by and among Berry Global, Inc., Berry Global Group, Inc., Berry Plastics
Canada Inc., RPC Group Limited, the lenders party thereto, Bank of America, N.A., as
collateral agent and administrative agent, and the financial institutions party thereto
(incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q
filed on August 9, 2023).
U.S. $1,200,000,000 Second Amended and Restated Credit Agreement, dated as of April 3,
2007, by and among Berry Plastics Corporation formerly known as Berry Plastics Holding
Corporation, Berry Plastics Group, Inc., Credit Suisse, Cayman Islands Branch, as collateral
and administrative agent, the lenders party thereto from time to time, and the other financial
institutions party thereto (incorporated by reference to Exhibit 10.1(b) to Berry Plastics
Corporation’s Current Report on Form 8-K filed on April 10, 2007).
Second Amended and Restated Intercreditor Agreement, dated as of February 5, 2008, by
and among Berry Plastics Group, Inc., Berry Plastics Corporation, certain subsidiaries
identified as parties thereto, Bank of America, N.A. and Credit Suisse, Cayman Islands
Branch as first lien agents, and U.S. Bank Trust Company National Association, as successor
in interest to Wells Fargo Bank, N.A., as trustee (incorporated by reference to Exhibit 10.3 to
the Company’s Annual Report on Form 10-K filed on November 23, 2015).
U.S. $1,147,500,000 and $814,375,000 Incremental Assumption Agreement, dated as of
February 10, 2017 by and among Berry Plastics Group, Inc., Berry Plastics Corporation and
certain of its subsidiaries referenced therein, Credit Suisse AG, Cayman Islands Branch, as
administrative agent for the lenders under the term loan credit agreement referenced therein,
Citibank, N.A., as initial Term K lender and Citibank, N.A., as incremental term L lender
therein. (incorporated by reference to Exhibit 10.7 to the Company’s Annual Report on
Form 10-K filed on November 21, 2017).
48
Exhibit No
10.5
10.6
10.7
10.8
10.9
10.10
10.11
10.12
10.13
Description of Exhibit
U.S. $1,644,750,000 and $498,750,000 Incremental Assumption Agreement, dated as of
August 10, 2017, by and among Berry Plastics Group, Inc., Berry Plastics Corporation and
certain of its subsidiaries referenced therein, Credit Suisse AG, Cayman Islands Branch, as
administrative agent for the lenders under the term loan credit agreement referenced therein,
Wells Fargo Bank, National Association, as initial Term M lender and Wells Fargo Bank,
National Association, as initial Term N lender therein (incorporated by reference to
Exhibit 10.8 to the Company’s Annual Report on Form 10-K filed on November 21, 2017).
U.S. $900,000,000 and $814,375,000 Incremental Assumption Agreement, dated as of
November 27, 2017, by and among Berry Global Group, Inc., Berry Global, Inc. and certain
of its subsidiaries referenced therein, Credit Suisse AG, Cayman Islands Branch, as
administrative agent for the lenders under the term loan credit agreement referenced therein,
Citibank, N.A., as initial Term O Lender, and Citibank, N.A., as initial Term P Lender
therein. (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on
Form 10-Q filed on February 7, 2018).
U.S. $1,644,750,000 and $496,250,000 Incremental Assumption Agreement and Amendment,
dated as of February 12, 2018, by and among Berry Global Group, Inc., Berry Global, Inc.
and certain of its subsidiaries referenced therein, Credit Suisse AG, Cayman Islands Branch,
as administrative agent for the lenders under the term loan credit agreement referenced
therein, Citibank, N.A., as initial Term Q lender, and Citibank, N.A., as initial Term R lender
therein (incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on
Form 10-Q filed on May 3, 2018).
U.S. $800,000,000 and $814,375,000 Incremental Assumption Agreement, dated as of
May 16, 2018, by and among Berry Global Group, Inc., Berry Global, Inc. and certain of its
subsidiaries referenced therein, Credit Suisse AG, Cayman Islands Branch, as administrative
agent for the lenders under the term loan credit agreement referenced therein, Citibank, N.A.,
as initial Term S lender, and Citibank, N.A., as initial Term T lender therein (incorporated by
reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed on
August 3, 2018).
Cooperation Agreement, dated November 22, 2022, by and among Berry Global Group, Inc.,
Ancora Catalyst Institutional, LP, Eminence Capital, L.P. and the other persons and entities
listed thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on
Form 8-K filed on November 23, 2022).
Amended and Restated Cooperation Agreement, dated October 18, 2023, by and among
Berry Global Group, Inc., Ancora Catalyst Institutional, LP, Eminence Capital, L.P. and the
other persons and entities listed thereto (incorporated by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K filed on October 20, 2023).
Amendment and Waiver to Equipment Lease Agreement, dated as of January 19, 2011,
between Chicopee, Inc., as Lessee and Gossamer Holdings, LLC, as Lessor (incorporated by
reference to Exhibit 10.16 to AVINTIV Specialty Materials Inc.’s Registration Statement
Form S-4 filed on October 25, 2011).
Second Amendment to Equipment Lease Agreement, dated as of October 7, 2011, between
Chicopee, Inc., as Lessee and Gossamer Holdings, LLC, as Lessor (incorporated by reference
to Exhibit 10.17 to AVINTIV Specialty Materials Inc.’s Registration Statement Form S-4
filed on October 25, 2011).
Third Amendment to Equipment Lease Agreement, dated as of February 28, 2012, between
Chicopee, Inc., as Lessee and Gossamer Holdings, LLC, as Lessor (incorporated by reference
to Exhibit 10.1 to AVINTIV Specialty Materials Inc.’s Quarterly Report on Form 10-Q filed
on May 15, 2012).
49
Exhibit No
10.14
10.15†
10.16†
10.17†
10.18†
10.19†
10.20†
10.21†
10.22†
10.23†
10.24†
10.25†
10.26†
10.27†
10.28†
Description of Exhibit
Fourth Amendment to Equipment Lease Agreement, dated as of March 22, 2013, between
Chicopee, Inc., as Lessee and Gossamer Holdings, LLC, as Lessor (incorporated by reference
to Exhibit 10.1 to AVINTIV Specialty Materials Inc.’s Quarterly Report on Form 10-Q filed
on May 9, 2013).
Employment Agreement of Thomas E. Salmon (incorporated by reference to Exhibit 10.1 to
the Company’s Current Report on Form 8-K filed on February 6, 2017).
Berry Plastics Group, Inc. Executive Bonus Plan, amended and restated December 22, 2015,
effective as of September 27, 2015 (incorporated by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K filed on December 28, 2015).
Berry Plastics Group, Inc. 2012 Long-Term Incentive Plan (incorporated by reference to
Exhibit 10.27 to the Company’s Annual Report on Form 10-K filed on December 17, 2012).
Amendment No. 1 to the Berry Plastics Group, Inc., 2012 Long-Term Incentive Plan
(incorporated by reference to Exhibit 10.31 to the Company’s Annual Report on Form 10-K
filed on December 11, 2013).
Omnibus amendment to awards granted under the Berry Plastics Group, Inc., 2012
Long-Term Incentive Plan (incorporated by reference to Exhibit 10.32 to the Company’s
Annual Report on Form 10-K filed on December 11, 2013).
Amendment No. 2 to the Berry Plastics Group, Inc. 2012 Long-Term Incentive Plan
(incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K
filed on March 10, 2015).
Form of 2016 Omnibus Amendment to Awards Granted Under the Berry Plastics Group,
Inc. 2012 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.3 to the
Company’s Current Report on Form 8-K filed on July 22, 2016).
2015 Berry Plastics Group, Inc. Long-Term Incentive Plan (incorporated by reference to
Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on March 10, 2015).
First Amendment to 2015 Berry Plastics Group, Inc. Long-Term Incentive Plan
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K
filed on March 6, 2018).
Form of 2016 Omnibus Amendment to Awards Granted Under the Berry Plastics Group,
Inc. 2015 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4 to the
Company’s Current Report on Form 8-K filed on July 22, 2016).
Fourth Amended and Restated Stockholders Agreement, by and among Berry Plastics
Group, Inc., and the stockholders of the Corporation listed on schedule A thereto, dated as
of January 15, 2015 (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly
Report on Form 10-Q filed on January 30, 2015).
Employment Agreement, dated January 1, 2002, between the Berry Plastics Corporation and
Curtis Begle (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report
on Form 10-Q filed on January 31, 2014).
Amendment No. 1 to Employment Agreement, dated as of September 13, 2006, by and
between the Berry Plastics Corporation and Curtis Begle (incorporated by reference to
Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q filed on January 31, 2014).
Amendment No. 2 to Employment Agreement, dated December 31, 2008, by and between the
Berry Plastics Corporation and Curtis Begle (incorporated by reference to Exhibit 10.4 to the
Company’s Quarterly Report on Form 10-Q filed on January 31, 2014).
50
Exhibit No
10.29†
10.30†
10.31†
10.32†
10.33†
10.34†
10.35†
10.36†
10.37†
10.38†
10.39†
10.40†
10.41†
10.42†
Description of Exhibit
Amendment No. 3 to Employment Agreement, dated August 1, 2010, by and between the
Berry Plastics Corporation and Curtis L. Begle (incorporated by reference to Exhibit 10.5 to
the Company’s Quarterly Report on Form 10-Q filed on January 31, 2014).
Amendment No. 4 to Employment Agreement, dated December 16, 2011, by and between the
Berry Plastics Corporation and Curtis L. Begle (incorporated by reference to Exhibit 10.6 to
the Company’s Quarterly Report on Form 10-Q filed on January 31, 2014).
Employment Agreement, dated February 28, 1998, between Berry Plastics Corporation and
Mark Miles, together with amendments dated February 28, 2003, September 13, 2006,
December 31, 2008, and December 31, 2011 (incorporated by reference to Exhibit 10.40 to
the Company’s Annual Report on Form 10-K filed on November 30, 2016).
Form of Amendment to Employment Agreement by and between Berry Plastics Corporation
and each of Curtis L Begle, Mark W. Miles, and Thomas E. Salmon (incorporated by
reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on July 22,
2016).
Senior Executive Employment Contract dated as of September 30, 2015 by and between PGI
Specialty Materials Inc. and Jean Marc Galvez, together with the International Assignment
Letter dated December 18, 2016 from Berry Global, Inc. (f/k/a Berry Plastics Corporation)
(incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q
filed on February 7, 2018).
Employment Agreement, dated December 16, 2010, between Berry Plastics Corporation and
Jason Greene, together with amendments dated December 31, 2011 and July 20, 2016
(incorporated by reference to Exhibit 10.43 to the Company’s Annual Report on Form 10-K
filed on November 23, 2020).
Amended and Restated Berry Global Group, Inc. 2015 Long-Term Incentive Plan, effective
February 24, 2021 (incorporated by reference to Exhibit 10.1 to the Company’s Current
Report on Form 8-K filed on February 25, 2021).
Form of Employee Non-Qualified Stock Option Award Agreement (incorporated by
reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on
November 30, 2020).
Form of Employee Performance-Based Stock Unit Award Agreement (incorporated by
reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on
November 30, 2020).
Form of Director Non-Qualified Stock Option Award Agreement (incorporated by reference
to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on November 30, 2020).
Employment Agreement, dated August 11, 2023, among Kevin Kwilinski, Berry Global
Group, Inc., and Berry Global, Inc. (incorporated by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K filed on August 17, 2023).
Memorandum of Understanding, dated August 11, 2023, among Thomas E. Salmon, Berry
Global Group, Inc., and Berry Global, Inc. (incorporated by reference to Exhibit 10.2 to the
Company’s Current Report on Form 8-K filed on August 17, 2023).
Berry Global Group, Inc. 2022 Dividend Equivalent Rights Plan (incorporated by reference
to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed on February 2, 2023).
Form of Notice of Dividend Equivalent Rights Award under the Berry Global Group, Inc.
2022 Dividend Equivalent Rights Plan (incorporated by reference to Exhibit 10.2 to the
Company’s Quarterly Report on Form 10-Q filed on February 2, 2023).
21.1*
Subsidiaries of the Registrant.
51
Exhibit No
Description of Exhibit
22.1*
23.1*
31.1*
31.2*
32.1*
32.2*
List of Subsidiary Guarantors.
Consent of Independent Registered Public Accounting Firm.
Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.
Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.
Section 1350 Certification of the Chief Executive Officer.
Section 1350 Certification of the Chief Financial Officer.
97.1†*
Berry Global Group, Inc. Amended and Restated Compensation Recovery Policy
101.INS
Inline XBRL Instance Document (the instance document does not appear in the Interactive
Data File because its XBRL tags are embedded within the Inline XBRL document).
101.SCH
Inline XBRL Taxonomy Extension Schema Document.
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104
Cover Page Interactive Date File (formatted as Inline XBRL and contained in Exhibit 101).
*
Filed or furnished herewith, as applicable.
† Management contract or compensatory plan or arrangement.
52
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized,
on the 17th day of November, 2023.
BERRY GLOBAL GROUP, INC.
By /s/ Kevin Kwilinski
Kevin Kwilinski
Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by
the following persons on behalf of the registrant and in the capacities and on the dates indicated:
Signature
Title
Date
/s/ Kevin Kwilinski
Kevin Kwilinski
Chief Executive Officer and Director
(Principal Executive Officer)
November 17, 2023
Chief Financial Officer (Principal Financial
Officer)
November 17, 2023
Executive Vice President and Controller
(Principal Accounting Officer)
November 17, 2023
/s/ Mark W. Miles
Mark W. Miles
/s/ James M. Till
James M. Till
/s/ B. Evan Bayh
B. Evan Bayh
/s/ Jonathan F. Foster
Jonathan F. Foster
/s/ Meredith R. Harper
Meredith R. Harper
/s/ Idalene F. Kesner
Idalene F. Kesner
/s/ Jill A. Rahman
Jill A. Rahman
/s/ Carl J. Rickertsen
Carl J. Rickertsen
Director
Director
Director
Director
Director
Director
/s/ Chaney M. Sheffield, Jr.
Chaney M. Sheffield Jr.
Director
53
November 17, 2023
November 17, 2023
November 17, 2023
November 17, 2023
November 17, 2023
November 17, 2023
November 17, 2023
Signature
Title
Date
/s/ Robert A. Steele
Robert A. Steele
/s/ Stephen E. Sterrett
Stephen E. Sterrett
/s/ Peter T. Thomas
Peter T. Thomas
/s/ Scott B. Ullem
Scott B. Ullem
Director
November 17, 2023
Chairman of the Board and Director
November 17, 2023
Director
Director
November 17, 2023
November 17, 2023
54
Non-Gaap Financial Measures*
Adjusted earnings per share and free cash flow as presented in this document, are supplemental
financial measures that are not required by, or presented in accordance with, generally accepted
accounting principles in the United States (“GAAP”). Reconciliations of such measures to GAAP
financial measures are provided below. Investors are urged to consider carefully the comparable
GAAP measures and the reconciliations to those measures provided. For further information, see the
accompanying Form 10-K.
2019
2020
2021
2022
2023
$3.00
$4.14
$5.30
$5.77
$4.95
Other expense
1.15
0.23
0.37
0.17
0.25
Restructuring & transaction activities
(0.93)
0.58
0.37
0.17
0.83
Amortization of intangibles from acquisition
1.23
2.04
2.08
1.94
1.98
Non-comparable items (tax & other)
0.29
(0.01)
(0.24)
(0.13)
-
Income tax impact on items above
(0.41)
(0.58)
(0.67)
(0.52)
(0.59)
Adjusted net income per diluted share
$4.33
$6.40
$7.21
$7.40
$7.42
Cash flow from operating activities
Additions to property, plant, and equipment, net
Non-U.S. GAAP free cash flow
2022
2023
$1,563
$1,615
(687)
(689)
$876
$926
In millions of dollars. Free cash flow and adjusted earnings per share are non-GAAP financial measures.
Stockholder Information
Corporate Headquarters
Berry Global Group, Inc.
101 Oakley Street
Evansville, Indiana 47710
812.424.2904
berryglobal.com
Investor Relations Contact
Dustin Stilwell
812.306.2964
ir@berryglobal.com
Annual Meeting of Shareholders
February 14, 2024, at 10:00 a.m. Central Time,
Bally’s Evansville Executive Conference Center—Room Walnut D
450 NW Riverside Dr., Evansville, Indiana 47708
Registrar and Transfer Agent
Computershare
P.O. Box 505000
Louisville, KY 40233
800.962.4284
Independent Registered Public Accounting Firm
Ernst & Young LLP
Additional Information
You can access financial and other information about Berry Global Group, Inc. at ir.berryglobal.com, including
press releases, Forms 10-K, 10-Q, and 8-K as filed with the Securities and Exchange Commission; and
information on Corporate Governance such as charters of Board Committees, our Global Code of Business
Ethics, and Corporate Governance Guidelines. You can also request that any of these materials be mailed to
you at no charge by writing us at the address above.
5146
1.877.662.3779 | berryglobal.com